<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title>PLoS ONE</journal-title><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19270747</article-id><article-id pub-id-type="pmc">2650263</article-id><article-id pub-id-type="publisher-id">08-PONE-RA-07765</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0004754</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Immunology/Immunity to Infections</subject><subject>Microbiology/Cellular Microbiology and Pathogenesis</subject><subject>Microbiology/Medical Microbiology</subject><subject>Gastroenterology and Hepatology/Gastrointestinal Cancers</subject><subject>Gastroenterology and Hepatology/Gastrointestinal Infections</subject><subject>Gastroenterology and Hepatology/Stomach and Duodenum</subject><subject>Infectious Diseases/Bacterial Infections</subject><subject>Infectious Diseases/Gastrointestinal Infections</subject><subject>Oncology/Gastrointestinal Cancers</subject><subject>Pathology/Histopathology</subject><subject>Pathology/Pathophysiology</subject><subject>Gastroenterology and Hepatology</subject><subject>Gastroenterology and Hepatology/Gastrointestinal Cancers</subject><subject>Gastroenterology and Hepatology/Gastrointestinal Infections</subject><subject>Gastroenterology and Hepatology/Stomach and Duodenum</subject><subject>Immunology/Immunity to Infections</subject><subject>Infectious Diseases/Bacterial Infections</subject><subject>Infectious Diseases/Gastrointestinal Infections</subject><subject>Microbiology/Cellular Microbiology and Pathogenesis</subject><subject>Microbiology/Medical Microbiology</subject><subject>Oncology/Gastrointestinal Cancers</subject><subject>Pathology/Histopathology</subject><subject>Pathology/Pathophysiology</subject></subj-group></article-categories><title-group><article-title><italic>Helicobacter pylori cag</italic>-Pathogenicity Island-Dependent Early Immunological Response Triggers Later Precancerous Gastric Changes in Mongolian Gerbils</article-title><alt-title alt-title-type="running-head"><italic>H. pylori</italic> Infection in Gerbils</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wiedemann</surname><given-names>Tobias</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Loell</surname><given-names>Eva</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Mueller</surname><given-names>Susanna</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Stoeckelhuber</surname><given-names>Mechthild</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Stolte</surname><given-names>Manfred</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Haas</surname><given-names>Rainer</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Rieder</surname><given-names>Gabriele</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Max-von-Pettenkofer-Institute for Hygiene and Medical Microbiology, Ludwig Maximilians University, Munich, Germany</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Institute of Pathology, Ludwig Maximilians University, Munich, Germany</addr-line></aff><aff id="aff3"><label>3</label><addr-line>Institute of Anatomy, Ludwig Maximilians University, Munich, Germany</addr-line></aff><aff id="aff4"><label>4</label><addr-line>Institute of Pathology, Klinikum Bayreuth GmbH, Bayreuth, Germany</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Ahmed</surname><given-names>Niyaz</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">University of Hyderabad, India</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>rieder@mvp.uni-muenchen.de</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: GR. Performed the experiments: TW EL MStoeckelhuber. Analyzed the data: TW EL SM MStoeckelhuber MStolte GR. Contributed reagents/materials/analysis tools: SM MStoeckelhuber MStolte RH. Wrote the paper: RH GR.</p></fn></author-notes><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>9</day><month>3</month><year>2009</year></pub-date><volume>4</volume><issue>3</issue><elocation-id>e4754</elocation-id><history><date date-type="received"><day>15</day><month>12</month><year>2008</year></date><date date-type="accepted"><day>14</day><month>1</month><year>2009</year></date></history><copyright-statement>Wiedemann et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement><copyright-year>2009</copyright-year><abstract><p>Infection with <italic>Helicobacter pylori</italic>, carrying a functional <italic>cag</italic> type IV secretion system (<italic>cag</italic>-T4SS) to inject the Cytotoxin associated antigen (CagA) into gastric cells, is associated with an increased risk for severe gastric diseases in humans. Here we studied the pathomechanism of <italic>H. pylori</italic> and the role of the <italic>cag</italic>-pathogenicity island (<italic>cag</italic>-PAI) for the induction of gastric ulcer and precancerous conditions over time (2&#x02013;64 weeks) using the Mongolian gerbil model. Animals were challenged with <italic>H. pylori</italic> B128 (WT), or an isogenic B128&#x00394;<italic>cagY</italic> mutant-strain that produces CagA, but is unable to translocate it into gastric cells. <italic>H. pylori</italic> colonization density was quantified in antrum and corpus mucosa separately. Paraffin sections were graded for inflammation and histological changes verified by immunohistochemistry. Physiological and inflammatory markers were quantitated by RIA and RT-PCR, respectively. An early <italic>cag</italic>-T4SS-dependent inflammation of the corpus mucosa (4&#x02013;8 weeks) occurred only in WT-infected animals, resulting in a severe active and chronic gastritis with a significant increase of proinflammatory cytokines, mucous gland metaplasia, and atrophy of the parietal cells. At late time points only WT-infected animals developed hypochlorhydria and hypergastrinemia in parallel to gastric ulcers, gastritis cystica profunda, and focal dysplasia. The early <italic>cag</italic>-PAI-dependent immunological response triggers later physiological and histopathological alterations towards gastric malignancies.</p></abstract><counts><page-count count="13"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>The bacterial pathogen <italic>Helicobacter pylori</italic> colonizes the human gastric mucosa of about 50&#x00025; of the world population to induce a chronic gastritis. As a consequence of an inflammation lasting for decades, gastric sequelae are developed like peptic ulcer and malignant diseases, such as gastric adenocarcinoma or MALT (mucosa-associated lymphoid tissue)-lymphoma <xref ref-type="bibr" rid="pone.0004754-Kuipers1">&#x0005b;1&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004754-Suerbaum1">&#x0005b;2&#x0005d;</xref>. Due to epidemiological studies the WHO declared <italic>H. pylori</italic> as a class I carcinogen in 1994 <xref ref-type="bibr" rid="pone.0004754-International1">&#x0005b;3&#x0005d;</xref>. Furthermore, a <italic>H. pylori</italic>-induced chronic inflammation in the human body represents a risk factor for developing gastric cancer <italic>per se</italic>. A malignant transformation of cells is usually a multi-factorial process <xref ref-type="bibr" rid="pone.0004754-Uemura1">&#x0005b;4&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004754-ElOmar1">&#x0005b;5&#x0005d;</xref>, which is also true for gastric carcinoma. In addition to <italic>H. pylori</italic> infection, environmental (diet, smoking) <xref ref-type="bibr" rid="pone.0004754-Tsugane1">&#x0005b;6&#x0005d;</xref> and host factors (gene polymorphisms, e.g. interleukin (IL)-1&#x003b2;) <xref ref-type="bibr" rid="pone.0004754-Peek1">&#x0005b;7&#x0005d;</xref> are certainly involved in its induction. Therefore the question remains what is the contribution of <italic>H. pylori</italic> for induction of gastric cancer.</p><p><italic>H. pylori</italic> produces a number of important virulence factors inducing a local inflammation in the stomach. Two major virulence factors have been studied intensively, the vacuolating cytotoxin A (VacA) <xref ref-type="bibr" rid="pone.0004754-Sewald1">&#x0005b;8&#x0005d;</xref> and the cytotoxin-associated antigen A (CagA). VacA is a secreted toxin that induces vacuoles in gastric epithelial cells, modulates cellular permeability, and enters immune cells via the &#x003b2;2 integrin receptor <xref ref-type="bibr" rid="pone.0004754-Sewald1">&#x0005b;8&#x0005d;</xref>. This is a possible mechanism for <italic>H. pylori</italic> to escape the adaptive immune system establishing a chronic inflammation. The <italic>cag</italic>-type IV secretion system (<italic>cag</italic>-T4SS), which is encoded on the <italic>cag</italic>-pathogenicity island (<italic>cag</italic>-PAI) <xref ref-type="bibr" rid="pone.0004754-Odenbreit1">&#x0005b;9&#x0005d;</xref> injects the effector protein CagA as well as peptidoglycan <xref ref-type="bibr" rid="pone.0004754-Viala1">&#x0005b;10&#x0005d;</xref>, resulting in activation of nuclear factor (NF)-&#x003ba;B and gastric inflammation. Translocated CagA is phosphorylated on certain tyrosine residues, leading to actin-cytoskeletal rearrangements, elongation, and the scattering phenotype of infected cells <italic>in vitro</italic>. The &#x0201c;needle&#x0201d;-like structure of the T4SS interacts with the integrin &#x003b1;5&#x003b2;1-receptor on the gastric epithelial cells, to deliver CagA into the host cells <xref ref-type="bibr" rid="pone.0004754-Kwok1">&#x0005b;11&#x0005d;</xref>, which finally leads to an activation of signal cascades inducing pro-inflammatory cytokines. Those <italic>H. pylori</italic> strains that express VacA and carry a complete and functional T4SS to translocate CagA into gastric host cells are designated as type I-strains, whereas type II-strains are defective in the <italic>cag</italic>-PAI and do not secrete functional VacA. Epidemiological studies have shown that type I-strains are associated with a more pronounced development of peptic ulcer and gastric cancer in humans <xref ref-type="bibr" rid="pone.0004754-Miehlke1">&#x0005b;12&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004754-Bach1">&#x0005b;13&#x0005d;</xref>.</p><p>To study the effect of <italic>H. pylori</italic> on the induction of gastroduodenal diseases different animal models have been established. <italic>H. pylori</italic> type I-strains are not fully virulent in mouse models, since they neither inject CagA, nor does VacA induce immunomodulation in murine T cells <xref ref-type="bibr" rid="pone.0004754-Sewald1">&#x0005b;8&#x0005d;</xref>. The mouse model is limited, since it cannot be used to recapitulate the <italic>cag</italic>-PAI dependent gastric carcinogenesis. It could be shown that infection of wild-type mice with <italic>cag</italic><sup>&#x0002b;</sup> strains frequently leads to deletions within the <italic>cag</italic>-PAI <xref ref-type="bibr" rid="pone.0004754-Philpott1">&#x0005b;14&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004754-Sozzi1">&#x0005b;15&#x0005d;</xref>. Therefore, the Mongolian gerbil model has been established to study <italic>H. pylori</italic> pathogenesis towards gastric adenocarcinoma <xref ref-type="bibr" rid="pone.0004754-Watanabe1">&#x0005b;16&#x0005d;</xref>.</p><p>In earlier studies analyzing only a single time point of infection (seven month) we could demonstrate that only a chronic infection of <italic>H. pylori</italic> type I-strain was able to induce an atrophic corpus-dominant gastritis in Mongolian gerbils <xref ref-type="bibr" rid="pone.0004754-Rieder1">&#x0005b;17&#x0005d;</xref>, which is a risk factor for developing gastric cancer. This observation was supported by human studies to be a precancerous condition, essential to be followed up tightly.</p><p>To gain more insight into the pathomechanisms of <italic>H. pylori</italic> and the role of the <italic>cag</italic>-PAI on the development of gastroduodenal diseases, we now performed a time course experiment. Mongolian gerbils were infected for 2, 4, 8, 16, 32, and 64 weeks with <italic>H. pylori</italic> B128 WT- (type I), or B128 &#x00394;<italic>cag</italic>Y mutant-strain (type II). Drastic differences were observed in the capacity of the B128 WT and the &#x00394;<italic>cag</italic>Y-mutant strain to colonize the gastric antrum and corpus mucosa inducing severe inflammation over time.</p><p>Our data suggest that an early inflammation in the antrum and especially in the corpus mucosa at eight weeks of infection, which is a <italic>cag</italic>-PAI-dependent mechanism, is triggering several months later physiological (hypochlorhydria and hypergastrinemia) and histopathological changes towards precancerous conditions. In general, our long-term <italic>in vivo</italic>-study reveals early markers for late gastric diseases that represent potential risk factors for precancerous transformation with a possible clinical application.</p></sec><sec sec-type="materials|methods" id="s2"><title>Materials and Methods</title><sec id="s2a"><title>Bacterial strains</title><p><italic>Helicobacter pylori</italic> B128, a Mongolian gerbil-adapted type I-strain (CagA, VacA: s1m2) <xref ref-type="bibr" rid="pone.0004754-Israel1">&#x0005b;18&#x0005d;</xref>, and its isogenic mutant B128&#x00394;<italic>cag</italic>Y (both streptomycin resistant) were used in this study as previous described <xref ref-type="bibr" rid="pone.0004754-Rieder1">&#x0005b;17&#x0005d;</xref>. Both strains carried a chromosomal streptomycin resistance that allowed quantitative recovery of <italic>H. pylori</italic> from the gerbil stomach by antibiotic selection (streptomycin 250 mg/L) <xref ref-type="bibr" rid="pone.0004754-Kavermann1">&#x0005b;19&#x0005d;</xref>. Each antral and corpus tissue specimen was homogenized (glass homogenizer, Ochs, Bovenden, Germany) in 1 ml Brucella broth, appropriate dilutions were spread on selective serum plates (GC agar (Oxoid, Wesel, Germany) supplemented with horse serum (8&#x00025;), vancomycin (10 mg/l), trimethoprim (5 mg/l), nystatin (1 mg/l)), and streptomycin (250 mg/l)), and incubated under microaerophilic conditions (85&#x00025; N<sub>2</sub>, 10&#x00025; CO<sub>2</sub>, 5&#x00025; O<sub>2</sub>) at 37&#x000b0;C for up to five days. Numbers of colony forming units (CFU) were expressed per gram of gastric tissue. <italic>H. pylori</italic> reisolates were tested for urease (urea broth, Oxoid), oxidase (DrySlide, BBL), and catalase (3&#x00025; hyperperoxid-solution) activity.</p></sec><sec id="s2b"><title>Animals and infection experiments</title><p>Outbred Mongolian gerbils (n&#x0200a;&#x0003d;&#x0200a;167 females) from our own breeding colony were specific pathogen free (SPF) and housed in SEALSAFE IVC cages (H-Temp, Tecniplast, Hohenpeissenberg, Germany) in an air-conditioned biohazard room (room temperature, 23&#x0002b;/&#x02212;2&#x000b0;C; relative humidity 55&#x0002b;/&#x02212;5&#x00025;; 12/12-h light/dark cycle) with free access to a commercial gerbil diet (ssniff Gerbil, SSNIFF, Soest, Germany) and sterile tap water. Animals at the age of 8&#x02013;12 weeks were challenged orogastrically three-times over five consecutive days with approximately 10<sup>9</sup> viable <italic>H. pylori</italic>. Age-matched control animals were inoculated with identical volumes of sterile Brucella broth alone. All experiments and procedures carried out were conducted in accordance with the Guidelines for the Care and Use of Laboratory Animals and approved by the Regierung von Oberbayern (AZ 55.2-1-54-2531-41/04 and 55.2-1-54-2531-78/05). The animals were sacrificed after specified time of infection (2, 4, 8, 16, 32, and 64 weeks), the stomach opened along the greater curvature, and the gastric tissue conserved separately in antrum and corpus as previous described <xref ref-type="bibr" rid="pone.0004754-Rieder1">&#x0005b;17&#x0005d;</xref>.</p></sec><sec id="s2c"><title>Histopathology</title><p>Paraffin embedded longitudinal sections of antrum and corpus were hematoxilin &#x00026; eosin (H&#x00026;E) stained for histomorphologic grading of gastritis and mucosal changes. The activity and chronicity of gastritis (scale 0&#x02013;3) were analyzed double blind according to the updated Sydney System <xref ref-type="bibr" rid="pone.0004754-Dixon1">&#x0005b;20&#x0005d;</xref> and the intensity of inflammation, metaplasia, and ulcer development (scale 0&#x02013;5) according to the grading scheme for rodents by Garhart <italic>et al.</italic> <xref ref-type="bibr" rid="pone.0004754-Garhart1">&#x0005b;21&#x0005d;</xref>. The presence of mucous gland metaplasia was confirmed by a periodic acid-Schiff (PAS)/Alcian blue stain (pH 2.5). The Cancer Risk Index was applied as previous described <xref ref-type="bibr" rid="pone.0004754-Meining1">&#x0005b;22&#x0005d;</xref>. In brief, an increased carcinoma risk was shown if active and chronic gastritis in corpus tissue was greater than in the antrum and if metaplastic changes were present.</p></sec><sec id="s2d"><title>Immunohistochemistry</title><p>Parietal cells were detected immunohistochemically by applying anti-proton pump (PP)-antibody (Medical &#x00026; Biological Laboratories, LTD, Naka-ku Nagoya, Japan). Positive-staining cells were visualized with diaminobenzidine (DAB) (Vectastain Elite ABC Kit; Vector Laboratories) and morphometrically analyzed with MetaMorph (Visitron, Puchheim Germany) software.</p><p>The evaluation of PP-positive cells as marker of the atrophy was performed using following score: 0, PP-positive cells distributed as in the non-infected control tissue; 1, small areas lacking PP-positive cells; 2, large areas without PP-positive cells; 3, no PP-positive cells in the entire tissue section.</p></sec><sec id="s2e"><title>pH measurement</title><p>The pH value of the gastric mucosa was measured at the corpus tissue using color-fixed indicator test sticks (pH-Fix 0.0&#x02013;6.0, Macherey-Nagel, Dueren, Germany).</p></sec><sec id="s2f"><title>Gastrin and somatostatin radioimmunoassay (RIA)</title><p>Plasma was isolated by centrifugation (9,000 rpm, 15 min at 4&#x000b0;C) from heparinized blood (2 ml) that was collected by cardiac puncture freshly after sacrifice of the animals. For the somatostatin RIA the plasma was extracted with Sep-Pak C18 cartridges (Waters GmbH, Eschborn, Germany). The gastrin- and somatostatin RIA were performed as described in the gastrin &#x0005b;<sup>125</sup>I&#x0005d; (MP Biomedicals, Heidelberg, Germany) and somatostatin &#x0005b;<sup>125</sup>I&#x0005d; (IBL, Hamburg, Germany) radioimmunoassay kits, respectively. Rabbit anti-human-gastrin (G-17) and -somatostatin (synthetic cyclic 14) antibodies in human serum albumin were used. The sensitivity of the gastrin and somatostatin assay was 3.3 pg/ml and 6.0 pg/ml, respectively.</p></sec><sec id="s2g"><title>RNA isolation and real-time RT-PCR</title><p>RNA isolation and real-time reverse transcription-polymerase chain reaction (RT-PCR) measurement were applied as described previously <xref ref-type="bibr" rid="pone.0004754-Rieder1">&#x0005b;17&#x0005d;</xref>. cDNA was synthesised using 1 &#x000b5;g total RNA, random hexamer oligonucleotide primers, and TaqMan Reverse Transcriptase Kit (Roche). Oligonucleotide primer and probes specific for IL-1&#x003b2;, interferon (IFN)-&#x003b3;, KC, somatostatin (Sst), IL-6, IL-10, tumor necrosis factor (TNF)-&#x003b1;, gastrin, histidine decarboxylase, and the housekeeping gene 18S rRNA (<xref ref-type="bibr" rid="pone.0004754-Rieder1">&#x0005b;17&#x0005d;</xref> and <xref ref-type="supplementary-material" rid="pone.0004754.s001">Table S1</xref>) were applied for real-time RT-PCR (ABI PRISM 7000, Applied Biosystems). All data were normalized with the corresponding 18S rRNA transcription level using a comparative delta Ct method.</p></sec><sec id="s2h"><title>Statistical Analysis</title><p>The results were statistically analyzed using the Mann-Whitney <italic>U</italic>-test for unpaired groups and the Fischer's Exact Test for inter-group differences. The p value &#x0003c;0.05 was considered as significant.</p></sec></sec><sec id="s3"><title>Results</title><sec id="s3a"><title>Colonization density <italic>of H. pylori</italic> wild type decreases in antrum and increases in corpus over time</title><p>Mongolian gerbils were orogastrically infected with <italic>H. pylori</italic> B128 wild type (WT) or <italic>H. pylori</italic> B128&#x00394;<italic>cag</italic>Y-mutant strains in a time course experiment of 2, 4, 8, 16, 32, and 64 weeks. In WT-infected gerbils a medial reisolation rate of 85&#x00025; was obtained, whereas all mutant-infected groups showed reisolation rates of 100&#x00025; (<xref ref-type="table" rid="pone-0004754-t001">Table 1</xref>). The reisolated <italic>H. pylori</italic> were selected by streptomycin to exclude growth of other gastric bacteria.</p><table-wrap id="pone-0004754-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004754.t001</object-id><label>Table 1</label><caption><title>Macroscopic and histopathological findings of <italic>Helicobacter pylori</italic>-infected and non-infected Mongolian gerbils.</title></caption><graphic id="pone-0004754-t001-1" xlink:href="pone.0004754.t001"/><table frame="hsides" rules="groups" alternate-form-of="pone-0004754-t001-1"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td colspan="3" align="left" rowspan="1">2 weeks</td><td colspan="3" align="left" rowspan="1">4 weeks</td><td colspan="3" align="left" rowspan="1">8 weeks</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Non-inf.</td><td align="left" rowspan="1" colspan="1">WT</td><td align="left" rowspan="1" colspan="1">&#x00394;<italic>cagY</italic></td><td align="left" rowspan="1" colspan="1">Non-inf.</td><td align="left" rowspan="1" colspan="1">WT</td><td align="left" rowspan="1" colspan="1">&#x00394;<italic>cagY</italic></td><td align="left" rowspan="1" colspan="1">Non-inf.</td><td align="left" rowspan="1" colspan="1">WT</td><td align="left" rowspan="1" colspan="1">&#x00394;<italic>cagY</italic></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(n/n) &#x00025;</td><td align="left" rowspan="1" colspan="1">(n/n) &#x00025;</td><td align="left" rowspan="1" colspan="1">(n/n) &#x00025;</td><td align="left" rowspan="1" colspan="1">(n/n) &#x00025;</td><td align="left" rowspan="1" colspan="1">(n/n) &#x00025;</td><td align="left" rowspan="1" colspan="1">(n/n) &#x00025;</td><td align="left" rowspan="1" colspan="1">(n/n) &#x00025;</td><td align="left" rowspan="1" colspan="1">(n/n) &#x00025;</td><td align="left" rowspan="1" colspan="1">(n/n) &#x00025;</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Number of animals</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">9</td></tr><tr><td align="left" rowspan="1" colspan="1">Reisolation rate</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(0/6) 0</td><td align="left" rowspan="1" colspan="1">(9/9) 100</td><td align="left" rowspan="1" colspan="1">(4/4) 100</td><td align="left" rowspan="1" colspan="1">(0/8) 0</td><td align="left" rowspan="1" colspan="1">(9/12) 75</td><td align="left" rowspan="1" colspan="1">(10/10) 100</td><td align="left" rowspan="1" colspan="1">(0/5) 0</td><td align="left" rowspan="1" colspan="1">(6/7) 86</td><td align="left" rowspan="1" colspan="1">(9/9) 100</td></tr><tr><td align="left" rowspan="1" colspan="1">Lymphoid aggregates</td><td align="left" rowspan="1" colspan="1">antrum</td><td align="left" rowspan="1" colspan="1">(0/6) 0</td><td align="left" rowspan="1" colspan="1">(0/9) 0</td><td align="left" rowspan="1" colspan="1">(0/4) 0</td><td align="left" rowspan="1" colspan="1">(0/8) 0</td><td align="left" rowspan="1" colspan="1">(1/9) 11</td><td align="left" rowspan="1" colspan="1">(0/10) 0</td><td align="left" rowspan="1" colspan="1">(0/5) 0</td><td align="left" rowspan="1" colspan="1">(6/6) 100</td><td align="left" rowspan="1" colspan="1">(5/9) 55</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">corpus</td><td align="left" rowspan="1" colspan="1">(0/6) 0</td><td align="left" rowspan="1" colspan="1">(0/9) 0</td><td align="left" rowspan="1" colspan="1">(0/4) 0</td><td align="left" rowspan="1" colspan="1">(0/8) 0</td><td align="left" rowspan="1" colspan="1">(0/9) 0</td><td align="left" rowspan="1" colspan="1">(0/10) 0</td><td align="left" rowspan="1" colspan="1">(0/5) 0</td><td align="left" rowspan="1" colspan="1">(6/6) 100</td><td align="left" rowspan="1" colspan="1">(1/9) 11</td></tr><tr><td align="left" rowspan="1" colspan="1">Erosion</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(0/6) 0</td><td align="left" rowspan="1" colspan="1">(0/9) 0</td><td align="left" rowspan="1" colspan="1">(0/4) 0</td><td align="left" rowspan="1" colspan="1">(0/8) 0</td><td align="left" rowspan="1" colspan="1">(1/9) 11</td><td align="left" rowspan="1" colspan="1">(0/10) 0</td><td align="left" rowspan="1" colspan="1">(0/5) 0</td><td align="left" rowspan="1" colspan="1">(6/6) 100</td><td align="left" rowspan="1" colspan="1">(4/9) 44</td></tr><tr><td align="left" rowspan="1" colspan="1">Ulcer</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(0/6) 0</td><td align="left" rowspan="1" colspan="1">(0/9) 0</td><td align="left" rowspan="1" colspan="1">(0/4) 0</td><td align="left" rowspan="1" colspan="1">(0/8) 0</td><td align="left" rowspan="1" colspan="1">(0/9) 0</td><td align="left" rowspan="1" colspan="1">(0/10) 0</td><td align="left" rowspan="1" colspan="1">(0/5) 0</td><td align="left" rowspan="1" colspan="1">(1/6) 17</td><td align="left" rowspan="1" colspan="1">(0/9) 0</td></tr><tr><td align="left" rowspan="1" colspan="1">Atrophy corpus<xref ref-type="table-fn" rid="nt101">A</xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(0/6) 0</td><td align="left" rowspan="1" colspan="1">(0/9) 0</td><td align="left" rowspan="1" colspan="1">(0/4) 0</td><td align="left" rowspan="1" colspan="1">(0/8) 0</td><td align="left" rowspan="1" colspan="1">(0/9) 0</td><td align="left" rowspan="1" colspan="1">(0/10) 0</td><td align="left" rowspan="1" colspan="1">(0/5) 0</td><td align="left" rowspan="1" colspan="1">(6/6) 100</td><td align="left" rowspan="1" colspan="1">(4/9) 44</td></tr><tr><td align="left" rowspan="1" colspan="1">Metaplastic changes</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(0/6) 0</td><td align="left" rowspan="1" colspan="1">(0/9) 0</td><td align="left" rowspan="1" colspan="1">(0/4) 0</td><td align="left" rowspan="1" colspan="1">(0/8) 0</td><td align="left" rowspan="1" colspan="1">(0/9) 0</td><td align="left" rowspan="1" colspan="1">(0/10) 0</td><td align="left" rowspan="1" colspan="1">(0/5) 0</td><td align="left" rowspan="1" colspan="1">(6/6) 100</td><td align="left" rowspan="1" colspan="1">(4/9) 44</td></tr><tr><td align="left" rowspan="1" colspan="1">Gastritis cystica profunda</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(0/6) 0</td><td align="left" rowspan="1" colspan="1">(0/9) 0</td><td align="left" rowspan="1" colspan="1">(0/4) 0</td><td align="left" rowspan="1" colspan="1">(0/8) 0</td><td align="left" rowspan="1" colspan="1">(0/9) 0</td><td align="left" rowspan="1" colspan="1">(0/10) 0</td><td align="left" rowspan="1" colspan="1">(0/5) 0</td><td align="left" rowspan="1" colspan="1">(1/6) 17</td><td align="left" rowspan="1" colspan="1">(0/9) 0</td></tr><tr><td align="left" rowspan="1" colspan="1">Focal dysplasia</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(0/6) 0</td><td align="left" rowspan="1" colspan="1">(0/9) 0</td><td align="left" rowspan="1" colspan="1">(0/4) 0</td><td align="left" rowspan="1" colspan="1">(0/8) 0</td><td align="left" rowspan="1" colspan="1">(0/9) 0</td><td align="left" rowspan="1" colspan="1">(0/10) 0</td><td align="left" rowspan="1" colspan="1">(0/5) 0</td><td align="left" rowspan="1" colspan="1">(0/6) 0</td><td align="left" rowspan="1" colspan="1">(0/9) 0</td></tr><tr><td align="left" rowspan="1" colspan="1">Increased carcinoma risk</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(0/6) 0</td><td align="left" rowspan="1" colspan="1">(0/9) 0</td><td align="left" rowspan="1" colspan="1">(0/4) 0</td><td align="left" rowspan="1" colspan="1">(0/8) 0</td><td align="left" rowspan="1" colspan="1">(0/9) 0</td><td align="left" rowspan="1" colspan="1">(0/10) 0</td><td align="left" rowspan="1" colspan="1">(0/5) 0</td><td align="left" rowspan="1" colspan="1">(0/6) 0</td><td align="left" rowspan="1" colspan="1">(0/9) 0</td></tr></tbody></table><table frame="hsides" rules="groups" alternate-form-of="pone-0004754-t001-1"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td colspan="3" align="left" rowspan="1">16 weeks</td><td colspan="3" align="left" rowspan="1">32 weeks</td><td colspan="3" align="left" rowspan="1">64 weeks</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Non-inf.</td><td align="left" rowspan="1" colspan="1">WT</td><td align="left" rowspan="1" colspan="1">&#x00394;<italic>cagY</italic></td><td align="left" rowspan="1" colspan="1">Non-inf.</td><td align="left" rowspan="1" colspan="1">WT</td><td align="left" rowspan="1" colspan="1">&#x00394;<italic>cagY</italic></td><td align="left" rowspan="1" colspan="1">Non-inf.</td><td align="left" rowspan="1" colspan="1">WT</td><td align="left" rowspan="1" colspan="1">&#x00394;<italic>cagY</italic></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(n/n) &#x00025;</td><td align="left" rowspan="1" colspan="1">(n/n) &#x00025;</td><td align="left" rowspan="1" colspan="1">(n/n) &#x00025;</td><td align="left" rowspan="1" colspan="1">(n/n) &#x00025;</td><td align="left" rowspan="1" colspan="1">(n/n) &#x00025;</td><td align="left" rowspan="1" colspan="1">(n/n) &#x00025;</td><td align="left" rowspan="1" colspan="1">(n/n) &#x00025;</td><td align="left" rowspan="1" colspan="1">(n/n) &#x00025;</td><td align="left" rowspan="1" colspan="1">(n/n) &#x00025;</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Number of animals</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">19</td><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">9</td></tr><tr><td align="left" rowspan="1" colspan="1">Reisolation rate</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(0/5) 0</td><td align="left" rowspan="1" colspan="1">(10/11) 91</td><td align="left" rowspan="1" colspan="1">(11/11) 100</td><td align="left" rowspan="1" colspan="1">(0/9) 0</td><td align="left" rowspan="1" colspan="1">(17/19) 89</td><td align="left" rowspan="1" colspan="1">(13/13) 100</td><td align="left" rowspan="1" colspan="1">(0/8) 0</td><td align="left" rowspan="1" colspan="1">(8/12) 66</td><td align="left" rowspan="1" colspan="1">(9/9) 100</td></tr><tr><td align="left" rowspan="1" colspan="1">Lymphoid aggregates</td><td align="left" rowspan="1" colspan="1">antrum</td><td align="left" rowspan="1" colspan="1">(0/5) 0</td><td align="left" rowspan="1" colspan="1">(10/10) 100</td><td align="left" rowspan="1" colspan="1">(9/11) 82</td><td align="left" rowspan="1" colspan="1">(0/9) 0</td><td align="left" rowspan="1" colspan="1">(17/17) 100</td><td align="left" rowspan="1" colspan="1">(13/13) 100</td><td align="left" rowspan="1" colspan="1">(0/8) 0</td><td align="left" rowspan="1" colspan="1">(8/8) 100</td><td align="left" rowspan="1" colspan="1">(9/9) 100</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">corpus</td><td align="left" rowspan="1" colspan="1">(0/5) 0</td><td align="left" rowspan="1" colspan="1">(7/10) 70</td><td align="left" rowspan="1" colspan="1">(0/11) 0</td><td align="left" rowspan="1" colspan="1">(0/9) 0</td><td align="left" rowspan="1" colspan="1">(15/17) 88</td><td align="left" rowspan="1" colspan="1">(4/13) 30</td><td align="left" rowspan="1" colspan="1">(0/8) 0</td><td align="left" rowspan="1" colspan="1">(8/8) 100<xref ref-type="table-fn" rid="nt102">&#x0002a;</xref></td><td align="left" rowspan="1" colspan="1">(3/9) 33</td></tr><tr><td align="left" rowspan="1" colspan="1">Erosion</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(0/5) 0</td><td align="left" rowspan="1" colspan="1">(10/10) 100</td><td align="left" rowspan="1" colspan="1">(3/11) 27</td><td align="left" rowspan="1" colspan="1">(0/9) 0</td><td align="left" rowspan="1" colspan="1">(17/17) 100</td><td align="left" rowspan="1" colspan="1">(6/13) 46</td><td align="left" rowspan="1" colspan="1">(0/8) 0</td><td align="left" rowspan="1" colspan="1">(8/8) 100</td><td align="left" rowspan="1" colspan="1">(8/9) 89</td></tr><tr><td align="left" rowspan="1" colspan="1">Ulcer</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(0/5) 0</td><td align="left" rowspan="1" colspan="1">(3/10) 30</td><td align="left" rowspan="1" colspan="1">(0/11) 0</td><td align="left" rowspan="1" colspan="1">(0/9) 0</td><td align="left" rowspan="1" colspan="1">(8/17) 47</td><td align="left" rowspan="1" colspan="1">(0/13) 0</td><td align="left" rowspan="1" colspan="1">(0/8) 0</td><td align="left" rowspan="1" colspan="1">(6/8) 75<xref ref-type="table-fn" rid="nt102">&#x0002a;</xref></td><td align="left" rowspan="1" colspan="1">(0/9) 0</td></tr><tr><td align="left" rowspan="1" colspan="1">Atrophy corpus<xref ref-type="table-fn" rid="nt101">A</xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(0/5) 0</td><td align="left" rowspan="1" colspan="1">(10/10) 100</td><td align="left" rowspan="1" colspan="1">(0/11) 0</td><td align="left" rowspan="1" colspan="1">(0/9) 0</td><td align="left" rowspan="1" colspan="1">(16/17) 94</td><td align="left" rowspan="1" colspan="1">(2/13) 15</td><td align="left" rowspan="1" colspan="1">(0/8) 0</td><td align="left" rowspan="1" colspan="1">(8/8) 100<xref ref-type="table-fn" rid="nt102">&#x0002a;</xref></td><td align="left" rowspan="1" colspan="1">(4/9) 44</td></tr><tr><td align="left" rowspan="1" colspan="1">Metaplastic changes</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(0/5) 0</td><td align="left" rowspan="1" colspan="1">(9/10) 90</td><td align="left" rowspan="1" colspan="1">(0/11) 0</td><td align="left" rowspan="1" colspan="1">(0/9) 0</td><td align="left" rowspan="1" colspan="1">(16/17) 94</td><td align="left" rowspan="1" colspan="1">(6/13) 46</td><td align="left" rowspan="1" colspan="1">(0/8) 0</td><td align="left" rowspan="1" colspan="1">(8/8) 100<xref ref-type="table-fn" rid="nt102">&#x0002a;</xref></td><td align="left" rowspan="1" colspan="1">(4/9) 44</td></tr><tr><td align="left" rowspan="1" colspan="1">Gastritis cystica profunda</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(0/5) 0</td><td align="left" rowspan="1" colspan="1">(0/10) 0</td><td align="left" rowspan="1" colspan="1">(0/11) 0</td><td align="left" rowspan="1" colspan="1">(0/9) 0</td><td align="left" rowspan="1" colspan="1">(4/17) 24</td><td align="left" rowspan="1" colspan="1">(1/13) 8</td><td align="left" rowspan="1" colspan="1">(0/8) 0</td><td align="left" rowspan="1" colspan="1">(6/8) 75<xref ref-type="table-fn" rid="nt102">&#x0002a;</xref></td><td align="left" rowspan="1" colspan="1">(4/9) 44</td></tr><tr><td align="left" rowspan="1" colspan="1">Focal dysplasia</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(0/5) 0</td><td align="left" rowspan="1" colspan="1">(1/10) 10</td><td align="left" rowspan="1" colspan="1">(0/11) 0</td><td align="left" rowspan="1" colspan="1">(0/9) 0</td><td align="left" rowspan="1" colspan="1">(1/17) 6</td><td align="left" rowspan="1" colspan="1">(0/13) 0</td><td align="left" rowspan="1" colspan="1">(0/8) 0</td><td align="left" rowspan="1" colspan="1">(2/8) 25<xref ref-type="table-fn" rid="nt102">&#x0002a;</xref></td><td align="left" rowspan="1" colspan="1">(0/9) 0</td></tr><tr><td align="left" rowspan="1" colspan="1">Increased carcinoma risk</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(0/5) 0</td><td align="left" rowspan="1" colspan="1">(3/10) 30</td><td align="left" rowspan="1" colspan="1">(0/11) 0</td><td align="left" rowspan="1" colspan="1">(0/9) 0</td><td align="left" rowspan="1" colspan="1">(12/17) 71</td><td align="left" rowspan="1" colspan="1">(1/13) 8</td><td align="left" rowspan="1" colspan="1">(0/8) 0</td><td align="left" rowspan="1" colspan="1">(6/8) 75<xref ref-type="table-fn" rid="nt102">&#x0002a;</xref></td><td align="left" rowspan="1" colspan="1">(0/9) 0</td></tr></tbody></table><table-wrap-foot><fn id="nt101"><label>A</label><p>parietal cell atrophy.</p></fn><fn id="nt102"><label>&#x0002a;</label><p>significant increase in comparison to mutant-infected group.</p></fn></table-wrap-foot></table-wrap><p>After two weeks both groups of infected animals started with a comparable colonization density of <italic>H. pylori</italic> in antrum and corpus of 10<sup>5</sup> and 10<sup>3</sup> CFU/g stomach, respectively (<xref ref-type="fig" rid="pone-0004754-g001">Figure 1A&#x02013;B</xref>). The B128 WT strain increased its density in the corpus slowly but continuously. After 16 weeks of infection the WT bacteria decreased their number in the antrum and equalized with the corpus colonizing bacteria at 10<sup>4</sup> CFU/g stomach at 32 weeks of infection. This colonization rate remained stable until 64 weeks of infection (<xref ref-type="fig" rid="pone-0004754-g001">Figure 1A&#x02013;B</xref>). The observed change in colonization density over time is clearly dependent on a functional <italic>cag</italic>-PAI, since the B128&#x00394;<italic>cagY</italic> mutant did not significantly change its bacterial density between 4 and 64 weeks, but maintained a constant difference (1&#x02013;1.5 log stages) in bacterial load between antral and corpus tissue. It was interesting to observe that the colonization density in the antrum of the mutant-infected gerbils was increased by &#x02265;1 log stage compared to the WT-infected groups.</p><fig id="pone-0004754-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004754.g001</object-id><label>Figure 1</label><caption><title>Increased <italic>Helicobacter pylori</italic> B128 WT colonization density shown in corpus mucosa over the time course experiment.</title><p>Colonization density of antral (white circles) and corpus (gray circles) mucosa in orally challenged gerbils with <italic>H. pylori</italic> B128 WT (A) and B128&#x00394;<italic>cag</italic>Y (B) isogenic mutant strain after 2, 4, 8, 16, 32, and 64 weeks of infection. The interpolated lines connect the medians of the respective time-points. The detection limit was &#x0003c;5&#x000d7;10<sup>2</sup> colony-forming units (CFU) per gram of stomach (horizontal dotted line). Gastric tissue specimens without <italic>H.pylori</italic> reisolation are shown as null. (&#x0002a;p&#x0003c;0.05).</p></caption><graphic xlink:href="pone.0004754.g001"/></fig></sec><sec id="s3b"><title>An early severe active and chronic gastritis as well as severe histological changes are only induced in wild type infected Mongolian gerbils</title><p>To investigate the dynamics of the host response, we analyzed the induction of the innate immune system by <italic>H. pylori</italic>-infection using histology. The grade of active and chronic gastritis in Mongolian gerbils was assessed by the density of neutrophil granulocytes, as well as lymphocytes, macrophages, and plasma cells infiltrating the gastric mucosa, respectively. In WT-infected animals, a severe active and chronic gastritis was observed in H&#x00026;E stained antral sections at eight weeks of infection (<xref ref-type="fig" rid="pone-0004754-g002">Figure 2A&#x02013;B</xref>). However, in the corpus, active and chronic gastritis gradually increased over time. In contrast to the WT-infected animals, gerbils infected with the B128 &#x00394;<italic>cag</italic>Y mutant revealed an attenuated progress of inflammation in antrum and corpus tissue. Only from 32 weeks of infection onwards the grading value in the antrum of mutant-infected animals reached the level of WT-infected animals (<xref ref-type="fig" rid="pone-0004754-g002">Figure 2A&#x02013;B</xref>).</p><fig id="pone-0004754-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004754.g002</object-id><label>Figure 2</label><caption><title>Induction of corpus dominant gastritis is B128 WT dependent.</title><p>Histological grading of antral (white triangles) and corpus (gray triangles) mucosa. Gerbils were orally challenged with <italic>H. pylori</italic> B128 WT (middle panels) and B128&#x00394;<italic>cag</italic>Y (bottom panels) isogenic mutant strain for 2, 4, 8, 16, 32, and 64 weeks compared with age-matched non-infected controls (upper panels). (A) Active gastritis and (B) chronic gastritis grading was performed according to the upgraded Sydney system, and (C) according to Garhart <italic>et al</italic>. The interpolated lines connect the medians of the respective time-points. (&#x0002a;p&#x0003c;0.05).</p></caption><graphic xlink:href="pone.0004754.g002"/></fig><p>Applying the grading system by Garhart <italic>et al.</italic> <xref ref-type="bibr" rid="pone.0004754-Garhart1">&#x0005b;21&#x0005d;</xref>, which includes the grade of metaplasia and ulcer development besides the intensity of inflammation, a significant increase at 8 weeks of infection was found in antral and corpus mucosa of WT-infected animals, but not in the corpus of mutant-infected gerbils (<xref ref-type="fig" rid="pone-0004754-g002">Figure 2C</xref>).</p><p>We conclude that in the antrum an early severe inflammation after 4 weeks of infection is dependent on a functional T4SS, inducing severe histological changes. After a delay of several months a strong antral inflammation is independent of CagA translocation, leading only to slight histological changes. In contrast, a severe inflammation in the corpus is only induced by a <italic>H. pylori</italic> type I-strain. Thus, our data clearly show a different pathomechanism in antrum and corpus mucosa.</p></sec><sec id="s3c"><title>Early precancerous conditions are observed at eight weeks of infection, but only with a <italic>H. pylori</italic> strain able to translocate CagA</title><p>Following the sequelae of <italic>H. pylori</italic>-associated chronic gastritis to gastric adenocarcinoma, several histological changes of the mucosa are usually involved, such as atrophy, metaplasia, and dysplasia. By means of H&#x00026;E as well as Alcian blue/PAS staining, we assessed histopathological changes of the gastric mucosa. The time course experiment revealed an increasing disturbance of the differentiation of the gastric mucosa beginning at 8 weeks of infection with <italic>H. pylori</italic> B128 (<xref ref-type="fig" rid="pone-0004754-g003">Figure 3A</xref>). In antrum and corpus of infected gerbils, the severe gastritis is followed by multiple lymphocyte aggregates in mucosa and submucosa, extensive hyperplasia of antral mucosa, a high degree of atrophy (loss of parietal cells) (<xref ref-type="fig" rid="pone-0004754-g003">Figure 3A&#x02013;B</xref>) in the corpus, and metaplastic changes (mucous gland metaplasia) in up to 100&#x00025; of WT-infected animals. The disturbance of the glandular mucosa is dramatically increasing over the time course in antrum and corpus of WT-infected animals, resulting in the formation of a regenerated epithelium (data not shown), but also a significant increase of gastritis cystica profunda (75&#x00025;), and focal dysplasia (25&#x00025;) occurred at 64 weeks of infection (<xref ref-type="fig" rid="pone-0004754-g003">Figure 3A</xref>, <xref ref-type="table" rid="pone-0004754-t001">Table 1</xref>). Severe neoplastic changes or gastric adenocarcinoma were not detected in any of the infected animals.</p><fig id="pone-0004754-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004754.g003</object-id><label>Figure 3</label><caption><title>Increased severity of inflammation in <italic>H. pylori</italic> B128 WT infected gerbils.</title><p>(A) H&#x00026;E and (B) alcian blue-PAS stained paraffin-embedded antral &#x0005b;A&#x0005d; and corpus &#x0005b;C&#x0005d; tissue (original magnification &#x000d7;10). Mucous gland metaplasia (black arrows) and gastritis cystica profunda (white arrows) are shown. Gerbils were orally challenged with <italic>H. pylori</italic> B128 WT (left panels) and B128&#x00394;<italic>cag</italic>Y isogenic mutant strain (right panels) for 2, 4, 8, 16, 32 and 64 weeks &#x0005b;w&#x0005d;.</p></caption><graphic xlink:href="pone.0004754.g003"/></fig><p>In contrast to WT-infected animals, mutant-infected groups revealed a less dramatic histopathological change of the antral mucosa over time. Although B128&#x00394;<italic>cag</italic>Y colonizes the corpus mucosa very efficiently (<xref ref-type="fig" rid="pone-0004754-g001">Figure 1B</xref>), this strain was not able to induce major histopathological changes, since the epithelial and glandular architecture was mainly preserved (<xref ref-type="fig" rid="pone-0004754-g003">Figure 3A</xref>, <xref ref-type="table" rid="pone-0004754-t001">Table 1</xref>). Thus, the histopathological changes seen in WT-infected gerbils are dependent on a functional T4SS.</p></sec><sec id="s3d"><title>A changing programme of mucus production in the gastric foveolae and gastric ulcer development due to infection with <italic>H. pylori</italic> type I-strain</title><p>By applying the Alcian blue/PAS stain, we determined changes in gastric mucus production during infection, staining paraffin sections red and blue for neutral and acid mucin, respectively (<xref ref-type="fig" rid="pone-0004754-g003">Figure 3B</xref>). Beginning at 8 weeks of infection, the neutral mucin secreting cells extended from the epithelium to the isthmus and down to the bottom of the foveolae of WT-infected antral and corpus mucosa (<xref ref-type="fig" rid="pone-0004754-g003">Figure 3B</xref>). In parallel, the red staining mucin at the top of the epithelium diminished considerably and the acid mucin secretion at the bottom of the antral glands disappeared entirely at 8 weeks of WT-infected gerbils. In contrast, the mutant-infected animals revealed less pronounced changes of the gastric mucin, indicating that a functional T4SS is important for reprogramming cells in terms of mucin production.</p><p>Another sequelae of chronic <italic>H. pylori</italic> gastritis is the development of gastric ulcer. Minor and large erosions of the gastric mucosa, which are precursor lesions of gastric ulcer, were present in 100&#x00025; of WT-infected animals from 8 weeks onwards. The mutant-infected animals, in contrast, required an additional year of infection, to achieve in 89&#x00025; of the animals a similar level of erosions (<xref ref-type="table" rid="pone-0004754-t001">Table 1</xref>). Furthermore, gastric ulcers were observed first in WT-infected gerbils after 8 weeks of infection (17&#x00025;) and increased in frequency up to 75&#x00025; at 64 weeks of infection. The macroscopic observation of an open stomach of WT-infected gerbils at 64 weeks of infection often showed penetrating ulcers and a loss of the architecture of the gastric mucosa (data not shown). Such pathological changes were not found in any of the mutant- or non-infected animals. Taken together, these observations demonstrate that in contrast to a type II-strain, only a <italic>H. pylori</italic> type I-strain is able to induce severe gastric diseases, such as gastric ulcer or precancerous lesions.</p></sec><sec id="s3e"><title>Atrophy of parietal cells in the corpus is dependent on the <italic>H. pylori</italic> T4SS</title><p>Since atrophy of the glandular mucosa is defined as the loss of parietal cells, we first analyzed the distribution of parietal cells in a horizontal section of the gastric mucosa of a non-infected gerbil stomach by immunohistochemistry. Parietal cells were mainly detected in the corpus but some in the antrum, too (<xref ref-type="fig" rid="pone-0004754-g004">Figure 4A</xref>). Therefore, we applied the grading for the atrophy not only to the corpus, but also to the antral tissue. The atrophy was classified into three stages, a beginning, moderate, and complete loss of parietal cells (<xref ref-type="fig" rid="pone-0004754-g004">Figure 4B</xref>).</p><fig id="pone-0004754-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004754.g004</object-id><label>Figure 4</label><caption><title>Distribution of parietal cells analyzed by immunohistochemical staining.</title><p>(A) Parietal cells were detected with anti-proton pump antibody in antral tissue (left panel), transition zone (middle panel), and corpus tissue (right panel) of non-infected Mongolian gerbils (original magnification 10&#x000d7;). (B) Immunohistochemical staining with anti-proton pump antibody detecting complete parietal cell atrophy in antral tissue at 64 weeks (left panel) and beginning at 8 weeks (middle panel) as well as complete parietal cell atrophy in corpus tissue at 16 weeks (right panel) of <italic>H. pylori</italic> B128 WT-infected gerbils. (C) Histological parietal cell atrophy grading of antral (white triangles) and corpus (gray triangles) mucosa infected with <italic>H. pylori</italic> B128 WT (upper panel) and B128&#x00394;<italic>cag</italic>Y isogenic mutant strain (bottom panel) over time. (&#x0002a;p&#x0003c;0.05).</p></caption><graphic xlink:href="pone.0004754.g004"/></fig><p>WT-infected gerbils revealed a significantly increased atrophy in antral and corpus mucosa after 4 weeks of infection (<xref ref-type="fig" rid="pone-0004754-g004">Figure 4C</xref>). However, mutant-infected animals showed only an atrophy in the antrum tissue but none in the corpus mucosa nearly until the end of the time-course experiment. These data suggest that in the antral mucosa atrophy is induced early after infection in a <italic>cag</italic>-PAI-independent manner, whereas the loss of huge numbers of parietal cells in the corpus is mainly dependent on the activity of the <italic>cag</italic>-T4SS of <italic>H. pylori</italic>.</p></sec><sec id="s3f"><title>Type I <italic>H. pylori</italic> increases the Cancer Risk Index for gastric carcinoma</title><p>The Cancer Risk Index <xref ref-type="bibr" rid="pone.0004754-Meining1">&#x0005b;22&#x0005d;</xref> describes important histological factors involved in promoting gastric cancerogenesis in humans, such as an increased inflammation in the corpus (corpus dominant active and chronic gastritis) as well as metaplastic changes of the mucosa. Applying this index to the gerbil model, we observed that at 16 weeks of WT-infection 30&#x00025; of the animals revealed an increased carcinoma risk index. This tendency further increased up to 75&#x00025; at 64 weeks of infection. In contrast, most of the mutant-infected animals did not fulfil these criteria (<xref ref-type="table" rid="pone-0004754-t001">Table 1</xref>). Therefore, mainly <italic>H. pylori</italic> type I-strains with a functional T4SS are able to induce precancerous conditions, such as a corpus dominant atrophic gastritis and metaplastic changes in a gerbil stomach.</p></sec><sec id="s3g"><title>Proinflammatory cytokine mRNA expression in antral and corpus tissue of WT-infected gerbils is drastically increased after four weeks of infection</title><p>The histological observed infiltration of inflammatory cells into the Lamina propria due to <italic>H. pylori</italic> infection was expected to be triggered by proinflammatory cytokines. To assess the level of cytokine mRNAs transcribed in the gastric tissue over the time course of infection, the cytokines IL-1&#x003b2;, TNF-&#x003b1;, IL-6, KC (IL-8 homologue), and IFN-&#x003b3; were quantified by real time RT-PCR. Between four and eight weeks of WT-infection, the proinflammatory cytokine mRNA levels increased significantly in the antrum and corpus mucosa and remained relatively stable in the antrum until 64 weeks, but continually increased in the corpus up to 16 weeks (<xref ref-type="fig" rid="pone-0004754-g005">Figure 5A&#x02013;E</xref>). Compared to basic expression levels in the non-infected control animal group the <italic>H. pylori</italic> WT-associated proinflammatory cytokine expression levels were induced about 25- to 200-fold in case of TNF-&#x003b1;, IL-6, KC, and IL-1&#x003b2; and even 700-fold for IFN-&#x003b3;.</p><fig id="pone-0004754-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004754.g005</object-id><label>Figure 5</label><caption><title>Early inflammatory events are reflected on mRNA level.</title><p>(A) IL-1&#x003b2;, (B) TNF-&#x003b1;, (C) IL-6, (D) KC, (E) IFN-&#x003b3;, and (F) IL-10 mRNA were measured by real-time RT-PCR normalized to 18S ribosomal RNA of antral and corpus mucosa of gerbils orally challenged with <italic>H. pylori</italic> B128 WT (red box) and B128&#x00394;<italic>cag</italic>Y (blue box) isogenic mutant strain for 2, 4, 8, 16, 32, and 64 weeks compared with age-matched non-infected controls (white box). All box plots show 25th to 75th percentiles (box) and 5th to 95th percentiles (whiskers). Solid dots are outliers below 5&#x00025; and above 95&#x00025;. The line in the box represents the median. The interpolated lines connect the medians of the respective time-points. (&#x0002a;p&#x0003c;0.05).</p></caption><graphic xlink:href="pone.0004754.g005"/></fig><p>The mutant-infected animals revealed a gradual increase of these cytokine mRNAs in the antrum up to 32 or 64 weeks of infection. In general, the mRNA levels were about one log stage below that of WT levels, except for TNF-&#x003b1;. Interestingly, all analyzed proinflammatory cytokine mRNAs in the corpus of mutant-infected gerbils were comparable to the non-infected control groups, i.e. expressed basic levels over the whole infection period (<xref ref-type="fig" rid="pone-0004754-g005">Figure 5A&#x02013;E</xref>).</p><p>In summary, the significant increase of cytokine mRNAs observed in antrum and corpus of WT-infected gerbils after 4 weeks clearly indicates a time-controlled <italic>cag</italic>-PAI-dependent mechanism of cytokine induction. At 8 weeks of infection there was a significant difference of mRNA levels in antral tissue between WT- and mutant-infected gerbils equalizing over time. These data suggest a two phase mechanism of cytokine induction in the antrum, an early <italic>cag</italic>-PAI dependent and a later <italic>cag</italic>-PAI-independent increase of proinflammatory cytokine mRNA expression by <italic>H. pylori</italic>.</p></sec><sec id="s3h"><title>IL-10, an anti-inflammatory cytokine, gradually increases over time of infection</title><p>To keep a chronic inflammation running, there has to be a balance of pro- and anti-inflammatory cytokines. The anti-inflammatory cytokine IL-10 is produced by T lymphocytes and regulatory T cells and is able to attenuate the inflammation of the gastric mucosa. Interestingly, the B128 type I-strain with a functional T4SS as well as the &#x00394;<italic>cag</italic>Y-mutant strain, both were able to gradually induce IL-10 mRNA in the antral and corpus mucosa during the time course experiment (<xref ref-type="fig" rid="pone-0004754-g005">Figure 5F</xref>). In contrast to the proinflammatory cytokines, the antral IL-10 mRNA level of WT-infected gerbils was not significantly induced after 4 weeks of infection, but constantly increased up to 15-fold after several months of infection. Whereas a significant increase of IL-10 mRNA expression was observed after 4 weeks infection in the corpus of WT-infected as well as in antrum and corpus of mutant-infected gerbils (<xref ref-type="fig" rid="pone-0004754-g005">Figure 5F</xref>). In conclusion we assume that the attenuated induction of an anti-inflammatory cytokine in the antral mucosa of WT-infected animals correlates with the significant increase of proinflammatory cytokines at 8 weeks of infection. This indicates IL-10 as a pivotal regulator of the <italic>H. pylori</italic>-induced chronic inflammation of the gastric mucosa.</p></sec><sec id="s3i"><title>Hypergastrinemia is following hypochlorhydria after 16 weeks of infection only in WT-infected gerbils</title><p>The effect of <italic>H. pylori</italic>-infection on physiological parameters (pH, gastrin) in the stomach was analyzed over time. In the control animals the gastric mucosa pH was on an average of pH 1.75. However in WT-infected gerbils, a significant increase of the pH value by 1.5 units was measured at 16 weeks. The pH values continued to rise gradually to pH 4.25 at 64 weeks of infection (<xref ref-type="fig" rid="pone-0004754-g006">Figure 6A</xref>). In contrast, the mutant-infected Mongolian gerbil stabilized their gastric pH during the long term infection at the level of the control group.</p><fig id="pone-0004754-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004754.g006</object-id><label>Figure 6</label><caption><title>Early inflammatory events cause later physiological changes in <italic>H. pylori</italic> B128 WT-infected gerbils.</title><p>The (A) pH and the (B) plasma gastrin level (detection limit &#x0003c;1 pmol/L) were determined of gerbils orally challenged with <italic>H. pylori</italic> B128 WT (middle panels) and B128&#x00394;<italic>cag</italic>Y (bottom panels) isogenic mutant strain for 2, 4, 8, 16, 32, and 64 weeks compared with age-matched non-infected controls (upper panels). (&#x0002a;p&#x0003c;0.05).</p></caption><graphic xlink:href="pone.0004754.g006"/></fig><p>Since gastrin expression is regulated by the gastric pH, we expected an increase of the gastrin level as a direct consequence of the pH changes. In fact, the WT-infected animals revealed a significant increase of plasma gastrin level at 32 weeks following a rise of the pH at 16 weeks of infection (compare <xref ref-type="fig" rid="pone-0004754-g006">Figure 6A&#x02013;B</xref>). In contrast, the non-infected control group and the B128&#x00394;<italic>cagY</italic>-infected animals showed very similar gastrin levels over time with a median of about 160 pg/ml. The data clearly show that the <italic>H. pylori</italic> WT-infection induces a relatively early increase of inflammatory markers (between 4 and 8 weeks) but a relatively late (at 16 and 32 weeks) increase in physiological parameters such as the gastric pH and the plasma gastrin level. Therefore we postulate that only an infection with a <italic>H. pylori</italic> type I-strain, carrying a functional T4SS able to interact with the host cells as well as translocate CagA and possibly other factors into the gastric cells, is a prerequisite to induce hypochlorhydria and hypergastrinema in the Mongolian gerbil model.</p></sec><sec id="s3j"><title>Gastric hormone mRNA concentrations are variably changed in type I <italic>H. pylori</italic> infections</title><p>Several gastric hormones are regulating the homoeostasis of the stomach. Gastrin produced in G-cells located in the antral stomach as well as histamine produced by the enzyme histidine decarboxylase in enterochromaffin-like (ECL) cells are inducing the acid secretion of parietal cells in the corpus mucosa, whereas somatostatin released from D-cells in the antral and corpus mucosa is an antagonist to gastrin and histamine down-regulating the acid secretion.</p><p>The gastrin and histidine decarboxylase mRNA concentration analyzed by real time RT-PCR decreased after 4 weeks significantly in antral tissue of WT-infected gerbils, but the concentrations in the corpus were constant over time (<xref ref-type="fig" rid="pone-0004754-g007">Figure 7A&#x02013;B</xref>). Interestingly, the observed reduction was gradually reversed after 16 weeks of infection. A further increase of gastrin mRNA levels by one log stage was obtained at 64 weeks of infection. However, for somatostatin a significant decrease of mRNA levels was measured not only in antral, but also in corpus mucosa after 4 weeks of infection (<xref ref-type="fig" rid="pone-0004754-g007">Figure 7C</xref>). Measuring the plasma somatostatin concentration by RIA, there was a reduced plasma somatostatin concentration between 8 and 64 weeks of infection in WT-infected gerbils (data not shown).</p><fig id="pone-0004754-g007" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004754.g007</object-id><label>Figure 7</label><caption><title>Decrease in gastrin-, histidine decarboxylase-, and somatostatin mRNA due to the <italic>H. pylori</italic> B128 WT-infection.</title><p>(A) Gastrin-, (B) histidine decarboxylase-, and (C) somatostatin mRNA were measured by real-time RT-PCR normalized to 18S ribosomal RNA of antral (white box) and corpus (gray box) mucosa of gerbils orally challenged with <italic>H. pylori</italic> B128 WT (middle panels) and B128&#x00394;<italic>cag</italic>Y (bottom panels) isogenic mutant strain for 2, 4, 8, 16, 32, and 64 weeks compared with age-matched non-infected controls (upper panels). All box plots show 25th to 75th percentiles (box) and 5th to 95th percentiles (whiskers). The line in the box represents the median. Solid dots are outliers below 5&#x00025; and above 95&#x00025;. The interpolated lines connect the medians of the respective time-points. (&#x0002a;p&#x0003c;0.05).</p></caption><graphic xlink:href="pone.0004754.g007"/></fig><p>Taken together our data reveal in WT-infected gerbils an early <italic>cag</italic>-PAI dependent down-regulation of hormones or enzymes involved in gastric homoeostasis on mRNA level, concomitantly with the early inflammation. However, those mRNA data are not directly correlating with the pH values and plasma gastrin levels observed after 16 weeks of infection. Thus, regulation of mRNA and protein levels is apparently separated by a time gap of several months and therefore possibly induced by two different mechanisms.</p></sec></sec><sec id="s4"><title>Discussion</title><p>The pathogenesis of <italic>H. pylori</italic>-associated gastritis involves immunological, histological, and physiological changes in the gastric mucosa. To get a better understanding about the role of <italic>H. pylori</italic> and its special virulence factors on the outcome of gastric disease, we used the Mongolian gerbil model in a long term infection experiment (2&#x02013;64 weeks). This animal model was chosen instead of the mouse model, since a <italic>H. pylori</italic> type I-strain is instable in the mouse and rapidly switches off the <italic>cag</italic>-T4SS.</p><p>Our data demonstrate convincingly that an intact <italic>cag</italic>-PAI and thus, a functional T4SS is responsible for nearly all of the observed pathological changes in the animals. The T4SS is essential for the induction of an early and severe corpus inflammation, associated with an increased expression of cytokines and histopathological changes. These cytokines seem to operate in a regulatory way on the physiology of the stomach, resulting in severe histological de-differentiation of the gastric mucosa towards the intestinal type. Therefore, this study elucidates mucosal atrophy and metaplasia as parts of the early pathomechanism due to <italic>H. pylori</italic> infection. We assume that an early reprogramming of gastric target cells via the <italic>cag</italic>-T4SS, probably by bacteria-host cell interaction and/or translocation of virulence factors, is responsible for a number of gastric changes. These are starting with an induction of severe chronic and atrophic gastritis, induction of pro-inflammatory cytokine gene transcription, finally leading to hypochlorhydria and hypergastrinemia, and late severe or malignant gastric diseases. The Mongolian gerbil model turns out to be an excellent model, to study these effects in detail. It very well mimics the human situation, with the advantage to interfere at defined stages of the process in order to eventually prevent these diseases. In a recent publication Ohnishi <italic>et al.</italic> revealed that a transgenic expression of <italic>H. pylori</italic> CagA induces gastrointestinal neoplasms in mouse <xref ref-type="bibr" rid="pone.0004754-Ohnishi1">&#x0005b;23&#x0005d;</xref> which supports our <italic>in vivo</italic>-data.</p><p>The difference in colonization density of <italic>H. pylori</italic> WT-strain in the stomach of Mongolian gerbils during the time course experiment revealed two <italic>cag</italic>-PAI dependent procedures: first, a reduced <italic>H. pylori</italic> density in antral mucosa and second, an increasing density in corpus mucosa, which both equalize after 32 weeks of infection. The first scenario might be explained by the development of gastric ulcers in the antrum, which correlates reciprocally with the density of the type I-strain in the gerbil stomach (<xref ref-type="fig" rid="pone-0004754-g001">Figure 1A</xref>), since <italic>H. pylori</italic> is unable to colonize ulcerous tissue. The second mechanism, explaining the procedure in the corpus, indicates that <italic>H. pylori</italic> type I-strain is continuously able to increase its load in parallel to the up-rise of the pH in the corpus mucosa of WT-infected gerbils. This reflects the destruction of parietal cells (atrophy), which is a <italic>cag</italic>-PAI dependent process.</p><p>Following the time course of our study, the first outstanding time point was between 4 and 8 weeks of infection. During these four weeks, the WT-infected gerbils presented already macroscopically an enlargement of the stomach size. At this early time point we assume that the translocated CagA might be active in inhibiting apoptosis, a process described recently in the Mongolian gerbil model <italic>in vivo</italic> <xref ref-type="bibr" rid="pone.0004754-Mimuro1">&#x0005b;24&#x0005d;</xref>.</p><p>Applying the grading system of Garhart <italic>et al.</italic> <xref ref-type="bibr" rid="pone.0004754-Garhart1">&#x0005b;21&#x0005d;</xref>, a significant increase of inflammation and histological changes were already seen after four weeks of <italic>H. pylori</italic> type I-infection. Interestingly, at 8 weeks 100&#x00025; of the infected animals developed numerous lymphoid aggregates and erosions, as well as an atrophy of the parietal cells and mucous gland metaplasia. These early observations are essential steps of the cancer pathway defined by Correa <xref ref-type="bibr" rid="pone.0004754-Correa1">&#x0005b;25&#x0005d;</xref> indicating that a functional T4SS is a pivotal risk factor for developing gastric cancer. Some scientists argue that gastric atrophy appears to be a better indicator of gastric cancer risk than intestinal metaplasia <xref ref-type="bibr" rid="pone.0004754-Fox1">&#x0005b;26&#x0005d;</xref>. Patients with gastric cancer of the intestinal type demonstrated a prevalence of atrophic gastritis (loss of oxyntic glands containing parietal cells) of 100&#x00025; <xref ref-type="bibr" rid="pone.0004754-ElZimaity1">&#x0005b;27&#x0005d;</xref> that is not associated with intestinal metaplasia, but strongly associated with a mucous metaplasia (pseudopyloric metaplasia), and therefore a further important precancerous stage <xref ref-type="bibr" rid="pone.0004754-Schmidt1">&#x0005b;28&#x0005d;</xref>. These observations are in accordance with our data presented here. A possible explanation is that the loss of parietal cells leads to a reduction of the secreted signal peptides that modulate the growth and differentiation of gastric progenitor cells, finally resulting in an increased proliferation of undifferentiated cells <xref ref-type="bibr" rid="pone.0004754-Fox1">&#x0005b;26&#x0005d;</xref>.</p><p>In contrast to the WT-infected animals, the mutant-infected gerbils, showed only a gradually increasing inflammation in the antral mucosa and minor histological changes (mainly erosions) over time. These changes are independent of the <italic>H. pylori cag</italic>-PAI. Thus, our data strongly support that a corpus predominant gastritis with a marked atrophy, as seen only in WT-infected gerbils, is associated with an increased risk for developing gastric adenocarcinoma <xref ref-type="bibr" rid="pone.0004754-Uemura1">&#x0005b;4&#x0005d;</xref>.</p><p>We and others have shown that a hypochlorhydria is associated with a hypergastrinemia in <italic>H. pylori</italic> WT-infected animals, since gastrin is regulating the acid homeostasis in the stomach via histamine in response to an alkaline environment <xref ref-type="bibr" rid="pone.0004754-Rieder1">&#x0005b;17&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004754-Fox1">&#x0005b;26&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004754-Takashima1">&#x0005b;29&#x0005d;</xref>. A complete atrophy of parietal cells in the corpus mucosa, in parallel to a stable G-cell differentiation in the antrum of the WT-infected gerbils supports the release of gastrin, resulting in a hypergastrinemia <xref ref-type="bibr" rid="pone.0004754-Fox2">&#x0005b;30&#x0005d;</xref>. Therefore, it can be assumed that an important role of <italic>H. pylori</italic> in gastric carcinogenesis is the induction of atrophic gastritis, resulting in hypochlorhydria.</p><p>Gastrin over-expressed in an insulin-gastrin transgenic mouse model (INSGAS) induces corpus atrophy in those mice, spontaneously progressing to gastric adenocarcinoma with advanced age <xref ref-type="bibr" rid="pone.0004754-Fox3">&#x0005b;31&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004754-Wang1">&#x0005b;32&#x0005d;</xref>. Furthermore, a parallel infection of those mice with <italic>Helicobacter</italic> spp. synergises with the effect of hypergastrinemia to accelerate the malignant transformation <xref ref-type="bibr" rid="pone.0004754-Wang2">&#x0005b;33&#x0005d;</xref>. We assume that a strong interaction of an early induced atrophy of the parietal cells together with a significantly increased stimulation of the G-cells in the antrum to release gastrin after 32 weeks of WT-infection, is responsible for severe precancerous transformations of the gastric cells. Thus, after 64 weeks of infection, gerbils challenged with a <italic>H. pylori</italic> type I-strain developed precancerous gastric changes, resulting in a statistically significant increase of gastritis cystica profunda (75&#x00025;) and focal dysplasia (25&#x00025;). Furthermore, WT-infected animals revealed an increased carcinoma risk index <xref ref-type="bibr" rid="pone.0004754-Meining1">&#x0005b;22&#x0005d;</xref> as compared to the mutant-infected ones, but none of the infected gerbils developed gastric adenocarcinoma. Our data are in agreement with several studies of western research groups <xref ref-type="bibr" rid="pone.0004754-Peek1">&#x0005b;7&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004754-Elfvin1">&#x0005b;34&#x0005d;</xref>, but contradicting published data from Japanese groups and others, that demonstrated a <italic>H. pylori</italic>-induced gastric cancer in Mongolian gerbils <xref ref-type="bibr" rid="pone.0004754-Watanabe1">&#x0005b;16&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004754-Honda1">&#x0005b;35&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004754-Ogura1">&#x0005b;36&#x0005d;</xref>. Thus, our data support a multifactorial process of gastric cancer induction, as it is suggested to occur in humans.</p><p><italic>H. pylori</italic> induces a Th1 immune response characterized by an infiltration of T-cells releasing proinflammatory cytokines <xref ref-type="bibr" rid="pone.0004754-Mohammadi1">&#x0005b;37&#x0005d;</xref>. The <italic>H. pylori</italic> colonization of the gastric mucosa results in expression of proinflammatory cytokines such as TNF-&#x003b1;, IL-1&#x003b2;, IL-8, and IFN-&#x003b3;, which attract leukocytes infiltrating the Lamina propria. This early rise of an inflammatory response is specific for a <italic>H. pylori</italic> type I-strain, whereas a late <italic>cag</italic>-PAI independent mechanism in the antral mucosa was described in mutant-infected gerbils, too. An IFN-&#x003b3; null mouse challenged with <italic>H. pylori</italic> shows no inflammatory response, even after more than one year of infection <xref ref-type="bibr" rid="pone.0004754-Sawai1">&#x0005b;38&#x0005d;</xref>. Thus, it has been suggested that those released proinflammatory cytokines, but especially IFN-&#x003b3;, possess a pivotal role in triggering cellular changes that contribute to gastric mucosal damage <xref ref-type="bibr" rid="pone.0004754-Sawai1">&#x0005b;38&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004754-Smythies1">&#x0005b;39&#x0005d;</xref>. Our data support this observation for early time points of 4 to 8 weeks of infection with a <italic>H. pylori</italic> type I-strain. But how does an early rise of cytokines relate to the later physiological and histological changes seen in WT-infected gerbils? We could show that the chronic gastritis is a precursor of the active gastritis in WT-infected gerbils (<xref ref-type="fig" rid="pone-0004754-g002">Figure 2B</xref>), since a mild inflammatory response was already observed by infiltrating of IFN-&#x003b3; expressing T-cells after two weeks of infection. IFN-&#x003b3; itself stimulates neutrophils to release proinflammatory cytokines such as TNF-&#x003b1;, IL-1&#x003b2;, and KC. Those cytokines together with IFN-&#x003b3; stimulate the G-cells in the antrum to release the hormone gastrin, but they also inhibit D-cells to express somatostatin, an inhibitor of gastrin-stimulated acid secretion. <xref ref-type="bibr" rid="pone.0004754-Peek1">&#x0005b;7&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004754-Zavros1">&#x0005b;40&#x0005d;</xref> IL-1&#x003b2; and TNF-&#x003b1; are potent inhibitors of parietal cells blocking acid secretion <xref ref-type="bibr" rid="pone.0004754-Beales1">&#x0005b;41&#x0005d;</xref>, and IL-1&#x003b2; decreases histamine release from enterochromaffin-like (ECL-) cells <xref ref-type="bibr" rid="pone.0004754-Prinz1">&#x0005b;42&#x0005d;</xref>. Furthermore, it was shown that TNF-&#x003b1; induces apoptosis of parietal cells <xref ref-type="bibr" rid="pone.0004754-Neu1">&#x0005b;43&#x0005d;</xref> and gastrin stimulates the hyperproliferation of the gastric epithelial cells, <xref ref-type="bibr" rid="pone.0004754-Dockray1">&#x0005b;44&#x0005d;</xref> thus an enhanced inflammation, as induced by a functional <italic>cag</italic>-PAI positive <italic>H. pylori</italic>-strain, is responsible for the progression of gastric preneoplastic lesion, such as atrophy and dysplasia, to adenocercinoma <xref ref-type="bibr" rid="pone.0004754-Takaishi1">&#x0005b;45&#x0005d;</xref>. In humans, carrying a <italic>H. pylori</italic> CagA-seropositive infection, an elevated IFN-&#x003b3; concentration was also detected that accounts for an increased plasma gastrin level <xref ref-type="bibr" rid="pone.0004754-Bamford1">&#x0005b;46&#x0005d;</xref>.</p><p>In contrast, the anti-inflammatory Th2 cytokine IL-4 stimulates the secretion of somatostatin <xref ref-type="bibr" rid="pone.0004754-Zavros2">&#x0005b;47&#x0005d;</xref>, thereby decreasing the development of gastric atrophy <xref ref-type="bibr" rid="pone.0004754-Fox4">&#x0005b;48&#x0005d;</xref>. <italic>H. pylori</italic> type II-strain infected gerbils revealed a significant increase of the anti-inflammatory cytokine IL-10 mRNA in antral and corpus tissue after four weeks of infection whereas, gerbils challenged with the type I-strain only gradually increased the IL-10 mRNA level in antral mucosa without any significance. Due to the reduced IL-10 expression in WT-infected gerbils, the Th1/Th2 equilibrium, which sustains a chronic inflammation, is deranged resulting in a hypergastrinemia and atrophy of the parietal cells in the oxyntic mucosa. Therefore, our results indicate a <italic>H. pylori</italic> type I-strain dependent early modulation of the immune response towards a Th1 response that is dominated by an IFN-&#x003b3; regulating cascade. This includes the stimulation of further proinflammatory Th1 cytokines that in the following regulate the gastric physiology resulting in severe histological changes such as precancerous lesions.</p><p>In conclusion, the Mongolian gerbil model is the only suitable rodent model available, mimicking the human situation, for analyzing the effect of major <italic>H. pylori</italic> virulence factors on the pathogenesis of the <italic>H. pylori</italic>-infected gastric mucosa. As our study reveals, we could standardize the gerbil model for investigating the complex interaction of immunological, physiological, and histological parameters in antral and corpus mucosa separately during a long-term <italic>H. pylori</italic>-infection experiment. Further clinical aspects of the pathogenesis of <italic>H. pylori</italic> towards gastric adenocarcinoma can now be addressed. In future, these results might be of therapeutic relevance.</p></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0004754.s001"><label>Table S1</label><caption><p>(0.08 MB DOC)</p></caption><media xlink:href="pone.0004754.s001.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ref-list><title>References</title><ref id="pone.0004754-Kuipers1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kuipers</surname><given-names>EJ</given-names></name><name><surname>Uyterlinde</surname><given-names>AM</given-names></name><name><surname>Pena</surname><given-names>AS</given-names></name><name><surname>Roosendaal</surname><given-names>R</given-names></name><name><surname>Pals</surname><given-names>G</given-names></name><etal/></person-group><year>1995</year><article-title>Long-term sequelae of Helicobacter pylori gastritis.</article-title><source>Lancet</source><volume>345</volume><fpage>1525</fpage><lpage>1528</lpage><pub-id pub-id-type="pmid">7791437</pub-id></citation></ref><ref id="pone.0004754-Suerbaum1"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Suerbaum</surname><given-names>S</given-names></name><name><surname>Michetti</surname><given-names>P</given-names></name></person-group><year>2002</year><article-title>Helicobacter pylori infection.</article-title><source>N Engl J Med</source><volume>347</volume><fpage>1175</fpage><lpage>1186</lpage><pub-id pub-id-type="pmid">12374879</pub-id></citation></ref><ref id="pone.0004754-International1"><label>3</label><citation citation-type="journal"><collab>International Agency for Research on Cancer</collab><year>1994</year><article-title>Schistosomes, liver flukes and <italic>Helicobacter pylori</italic>. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7&#x02013;14 June 1994.</article-title><source>IARC Monogr Eval Carcinog Risks Hum</source><volume>61</volume><fpage>1</fpage><lpage>241</lpage><pub-id pub-id-type="pmid">7715068</pub-id></citation></ref><ref id="pone.0004754-Uemura1"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Uemura</surname><given-names>N</given-names></name><name><surname>Okamoto</surname><given-names>S</given-names></name><name><surname>Yamamoto</surname><given-names>S</given-names></name><name><surname>Matsumura</surname><given-names>N</given-names></name><name><surname>Yamaguchi</surname><given-names>S</given-names></name><etal/></person-group><year>2001</year><article-title>Helicobacter pylori infection and the development of gastric cancer.</article-title><source>N Engl J Med</source><volume>345</volume><fpage>784</fpage><lpage>789</lpage><pub-id pub-id-type="pmid">11556297</pub-id></citation></ref><ref id="pone.0004754-ElOmar1"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>El-Omar</surname><given-names>EM</given-names></name><name><surname>Carrington</surname><given-names>M</given-names></name><name><surname>Chow</surname><given-names>WH</given-names></name><name><surname>McColl</surname><given-names>KE</given-names></name><name><surname>Bream</surname><given-names>JH</given-names></name><etal/></person-group><year>2000</year><article-title>Interleukin-1 polymorphisms associated with increased risk of gastric cancer.</article-title><source>Nature</source><volume>404</volume><fpage>398</fpage><lpage>402</lpage><pub-id pub-id-type="pmid">10746728</pub-id></citation></ref><ref id="pone.0004754-Tsugane1"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsugane</surname><given-names>S</given-names></name></person-group><year>2005</year><article-title>Salt, salted food intake, and risk of gastric cancer: epidemiologic evidence.</article-title><source>Cancer Sci</source><volume>96</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">15649247</pub-id></citation></ref><ref id="pone.0004754-Peek1"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peek</surname><given-names>RM</given-names><suffix>Jr</suffix></name><name><surname>Crabtree</surname><given-names>JE</given-names></name></person-group><year>2006</year><article-title>Helicobacter infection and gastric neoplasia.</article-title><source>j Pathol</source><volume>208</volume><fpage>233</fpage><lpage>248</lpage><pub-id pub-id-type="pmid">16362989</pub-id></citation></ref><ref id="pone.0004754-Sewald1"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sewald</surname><given-names>X</given-names></name><name><surname>Gebert-Vogl</surname><given-names>B</given-names></name><name><surname>Prassl</surname><given-names>S</given-names></name><name><surname>Barwig</surname><given-names>I</given-names></name><name><surname>Weiss</surname><given-names>E</given-names></name><etal/></person-group><year>2008</year><article-title>Integrin Subunit CD18 Is the T-Lymphocyte Receptor for the Helicobacter pylori Vacuolating Cytotoxin.</article-title><source>Cell Host Microbe</source><volume>3</volume><fpage>20</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">18191791</pub-id></citation></ref><ref id="pone.0004754-Odenbreit1"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Odenbreit</surname><given-names>S</given-names></name><name><surname>P&#x000fc;ls</surname><given-names>J</given-names></name><name><surname>Sedlmaier</surname><given-names>B</given-names></name><name><surname>Gerland</surname><given-names>E</given-names></name><name><surname>Fischer</surname><given-names>W</given-names></name><name><surname>Haas</surname><given-names>R</given-names></name></person-group><year>2000</year><article-title>Translocation of <italic>Helicobacter pylori</italic> CagA into gastric epithelial cells by type IV secretion.</article-title><source>Science</source><volume>287</volume><fpage>1497</fpage><lpage>1500</lpage><pub-id pub-id-type="pmid">10688800</pub-id></citation></ref><ref id="pone.0004754-Viala1"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Viala</surname><given-names>J</given-names></name><name><surname>Chaput</surname><given-names>C</given-names></name><name><surname>Boneca</surname><given-names>IG</given-names></name><name><surname>Cardona</surname><given-names>A</given-names></name><name><surname>Girardin</surname><given-names>SE</given-names></name><etal/></person-group><year>2004</year><article-title>Nod1 responds to peptidoglycan delivered by the <italic>Helicobacter pylori cag</italic> pathogenicity island.</article-title><source>Nat Immunol</source><volume>5</volume><fpage>1166</fpage><lpage>1174</lpage><pub-id pub-id-type="pmid">15489856</pub-id></citation></ref><ref id="pone.0004754-Kwok1"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kwok</surname><given-names>T</given-names></name><name><surname>Zabler</surname><given-names>D</given-names></name><name><surname>Urman</surname><given-names>S</given-names></name><name><surname>Rohde</surname><given-names>M</given-names></name><name><surname>Hartig</surname><given-names>R</given-names></name><etal/></person-group><year>2007</year><article-title>Helicobacter exploits integrin for type IV secretion and kinase activation.</article-title><source>Nature</source><volume>449</volume><fpage>862</fpage><lpage>866</lpage><pub-id pub-id-type="pmid">17943123</pub-id></citation></ref><ref id="pone.0004754-Miehlke1"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miehlke</surname><given-names>S</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Schuppler</surname><given-names>M</given-names></name><name><surname>Frings</surname><given-names>C</given-names></name><name><surname>Kirsch</surname><given-names>C</given-names></name><etal/></person-group><year>2001</year><article-title>Helicobacter pylori vacA, iceA, and cagA status and pattern of gastritis in patients with malignant and benign gastroduodenal disease.</article-title><source>Am J Gastroenterol</source><volume>96</volume><fpage>1008</fpage><lpage>1013</lpage><pub-id pub-id-type="pmid">11316139</pub-id></citation></ref><ref id="pone.0004754-Bach1"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bach</surname><given-names>S</given-names></name><name><surname>Makristathis</surname><given-names>A</given-names></name><name><surname>Pinto</surname><given-names>A</given-names></name><name><surname>Quina</surname><given-names>M</given-names></name><name><surname>Rotter</surname><given-names>M</given-names></name><name><surname>Hirschl</surname><given-names>AM</given-names></name></person-group><year>1999</year><article-title>Helicobacter pylori type I strains among Austrian and Portuguese patients with gastritis, peptic ulcer or gastric cancer.</article-title><source>Eur J Clin Microbiol Infect Dis</source><volume>18</volume><fpage>807</fpage><lpage>810</lpage><pub-id pub-id-type="pmid">10614956</pub-id></citation></ref><ref id="pone.0004754-Philpott1"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Philpott</surname><given-names>DJ</given-names></name><name><surname>Belaid</surname><given-names>D</given-names></name><name><surname>Troubadour</surname><given-names>P</given-names></name><name><surname>Thiberge</surname><given-names>JM</given-names></name><name><surname>Tankovic</surname><given-names>J</given-names></name><etal/></person-group><year>2002</year><article-title>Reduced activation of inflammatory responses in host cells by mouse-adapted Helicobacter pylory isolates.</article-title><source>Cell Microbiol</source><volume>4</volume><fpage>285</fpage><lpage>296</lpage><pub-id pub-id-type="pmid">12064285</pub-id></citation></ref><ref id="pone.0004754-Sozzi1"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sozzi</surname><given-names>M</given-names></name><name><surname>Crosatti</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>SK</given-names></name><name><surname>Romero</surname><given-names>J</given-names></name><name><surname>Blaser</surname><given-names>MJ</given-names></name></person-group><year>2001</year><article-title>Heterogeneity of Helicobacter pylori cag genotypes in experimentally infected mice.</article-title><source>FEMS Microbiol Lett</source><volume>203</volume><fpage>109</fpage><lpage>114</lpage><pub-id pub-id-type="pmid">11557148</pub-id></citation></ref><ref id="pone.0004754-Watanabe1"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Tada</surname><given-names>M</given-names></name><name><surname>Nagai</surname><given-names>H</given-names></name><name><surname>Sasaki</surname><given-names>S</given-names></name><name><surname>Nakao</surname><given-names>M</given-names></name></person-group><year>1998</year><article-title><italic>Helicobacter pylori</italic> infection induces gastric cancer in mongolian gerbils.</article-title><source>Gastroenterol</source><volume>115</volume><fpage>642</fpage><lpage>648</lpage></citation></ref><ref id="pone.0004754-Rieder1"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rieder</surname><given-names>G</given-names></name><name><surname>Merchant</surname><given-names>JL</given-names></name><name><surname>Haas</surname><given-names>R</given-names></name></person-group><year>2005</year><article-title>Helicobacter pylori <italic>cag</italic>-Type IV Secretion System Facilitates Corpus Colonization to Induce Precancerous Conditions in Mongolian Gerbils.</article-title><source>Gastroenterol</source><volume>128</volume><fpage>1229</fpage><lpage>1242</lpage></citation></ref><ref id="pone.0004754-Israel1"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Israel</surname><given-names>DA</given-names></name><name><surname>Salama</surname><given-names>N</given-names></name><name><surname>Arnold</surname><given-names>CN</given-names></name><name><surname>Moss</surname><given-names>SF</given-names></name><name><surname>Ando</surname><given-names>T</given-names></name><etal/></person-group><year>2001</year><article-title>Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses.</article-title><source>J Clin Invest</source><volume>107</volume><fpage>611</fpage><lpage>620</lpage><pub-id pub-id-type="pmid">11238562</pub-id></citation></ref><ref id="pone.0004754-Kavermann1"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kavermann</surname><given-names>H</given-names></name><name><surname>Burns</surname><given-names>BP</given-names></name><name><surname>Angermuller</surname><given-names>K</given-names></name><name><surname>Odenbreit</surname><given-names>S</given-names></name><name><surname>Fischer</surname><given-names>W</given-names></name><etal/></person-group><year>2003</year><article-title>Identification and characterization of Helicobacter pylori genes essential for gastric colonization.</article-title><source>J Exp Med</source><volume>197</volume><fpage>813</fpage><lpage>822</lpage><pub-id pub-id-type="pmid">12668646</pub-id></citation></ref><ref id="pone.0004754-Dixon1"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dixon</surname><given-names>MF</given-names></name><name><surname>Genta</surname><given-names>RM</given-names></name><name><surname>Yardley</surname><given-names>JH</given-names></name><name><surname>Correa</surname><given-names>P</given-names></name></person-group><year>1996</year><article-title>Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994.</article-title><source>Am J Surg Pathol</source><volume>20</volume><fpage>1161</fpage><lpage>1181</lpage><pub-id pub-id-type="pmid">8827022</pub-id></citation></ref><ref id="pone.0004754-Garhart1"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garhart</surname><given-names>CA</given-names></name><name><surname>Redline</surname><given-names>RW</given-names></name><name><surname>Nedrud</surname><given-names>JG</given-names></name><name><surname>Czinn</surname><given-names>SJ</given-names></name></person-group><year>2002</year><article-title>Clearance of Helicobacter pylori Infection and Resolution of Postimmunization Gastritis in a Kinetic Study of Prophylactically Immunized Mice.</article-title><source>Infect Immun</source><volume>70</volume><fpage>3529</fpage><lpage>3538</lpage><pub-id pub-id-type="pmid">12065492</pub-id></citation></ref><ref id="pone.0004754-Meining1"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meining</surname><given-names>A</given-names></name><name><surname>Bayerdorffer</surname><given-names>E</given-names></name><name><surname>Muller</surname><given-names>P</given-names></name><name><surname>Miehlke</surname><given-names>S</given-names></name><name><surname>Lehn</surname><given-names>N</given-names></name><etal/></person-group><year>1998</year><article-title>Gastric carcinoma risk index in patients infected with Helicobacter pylori.</article-title><source>Virchows Arch</source><volume>432</volume><fpage>311</fpage><lpage>314</lpage><pub-id pub-id-type="pmid">9565339</pub-id></citation></ref><ref id="pone.0004754-Ohnishi1"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ohnishi</surname><given-names>N</given-names></name><name><surname>Yuasa</surname><given-names>H</given-names></name><name><surname>Tanaka</surname><given-names>S</given-names></name><name><surname>Sawa</surname><given-names>H</given-names></name><name><surname>Miura</surname><given-names>M</given-names></name><etal/></person-group><year>2008</year><article-title>Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse.</article-title><source>Proc Natl Acad Sci U S A</source><volume>105</volume><fpage>1003</fpage><lpage>1008</lpage><pub-id pub-id-type="pmid">18192401</pub-id></citation></ref><ref id="pone.0004754-Mimuro1"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mimuro</surname><given-names>H</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Nagai</surname><given-names>S</given-names></name><name><surname>Rieder</surname><given-names>G</given-names></name><name><surname>Suzuki</surname></name><etal/></person-group><year>2007</year><article-title>Helicobacter pylori dampens gut epithelial self-renewal by inhibiting apoptosis, a bacterial strategy to enhance colonization of the stomach.</article-title><source>Cell Host Microbe</source><volume>2</volume><fpage>250</fpage><lpage>263</lpage><pub-id pub-id-type="pmid">18005743</pub-id></citation></ref><ref id="pone.0004754-Correa1"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Correa</surname><given-names>P</given-names></name></person-group><year>1988</year><article-title>A human model of gastric carcinogenesis.</article-title><source>Cancer Res</source><volume>48</volume><fpage>3554</fpage><lpage>3560</lpage><pub-id pub-id-type="pmid">3288329</pub-id></citation></ref><ref id="pone.0004754-Fox1"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>JG</given-names></name><name><surname>Wang</surname><given-names>TC</given-names></name></person-group><year>2007</year><article-title>Inflammation, atrophy, and gastric cancer.</article-title><source>J Clin Invest</source><volume>117</volume><fpage>60</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">17200707</pub-id></citation></ref><ref id="pone.0004754-ElZimaity1"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>El-Zimaity</surname><given-names>HM</given-names></name><name><surname>Ota</surname><given-names>H</given-names></name><name><surname>Graham</surname><given-names>DY</given-names></name><name><surname>Akamatsu</surname><given-names>T</given-names></name><name><surname>Katsuyama</surname><given-names>T</given-names></name></person-group><year>2002</year><article-title>Patterns of gastric atrophy in intestinal type gastric carcinoma.</article-title><source>Cancer</source><volume>94</volume><fpage>1428</fpage><lpage>1436</lpage><pub-id pub-id-type="pmid">11920498</pub-id></citation></ref><ref id="pone.0004754-Schmidt1"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>PH</given-names></name><name><surname>Lee</surname><given-names>JR</given-names></name><name><surname>Joshi</surname><given-names>V</given-names></name><name><surname>Playford</surname><given-names>RJ</given-names></name><name><surname>Poulsom</surname><given-names>R</given-names></name><etal/></person-group><year>1999</year><article-title>Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma.</article-title><source>Lab Invest</source><volume>79</volume><fpage>639</fpage><lpage>646</lpage><pub-id pub-id-type="pmid">10378506</pub-id></citation></ref><ref id="pone.0004754-Takashima1"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takashima</surname><given-names>M</given-names></name><name><surname>Furuta</surname><given-names>T</given-names></name><name><surname>Hanai</surname><given-names>H</given-names></name><name><surname>Sugimura</surname><given-names>H</given-names></name><name><surname>Kaneko</surname><given-names>E</given-names></name></person-group><year>2001</year><article-title>Effects of Helicobacter pylori infection on gastric acid secretion and serum gastrin levels in Mongolian gerbils.</article-title><source>Gut</source><volume>48</volume><fpage>765</fpage><lpage>773</lpage><pub-id pub-id-type="pmid">11358893</pub-id></citation></ref><ref id="pone.0004754-Fox2"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>JG</given-names></name><name><surname>Wang</surname><given-names>TC</given-names></name><name><surname>Rogers</surname><given-names>AB</given-names></name><name><surname>Poutahidis</surname><given-names>T</given-names></name><name><surname>Ge</surname><given-names>Z</given-names></name><etal/></person-group><year>2003</year><article-title>Host and microbial constituents influence Helicobacter pylori-induced cancer in a murine model of hypergastrinemia.</article-title><source>Gastroenterol</source><volume>124</volume><fpage>1879</fpage><lpage>1890</lpage></citation></ref><ref id="pone.0004754-Fox3"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>JG</given-names></name><name><surname>Rogers</surname><given-names>AB</given-names></name><name><surname>Ihrig</surname><given-names>M</given-names></name><name><surname>Taylor</surname><given-names>NS</given-names></name><name><surname>Whary</surname><given-names>MT</given-names></name><etal/></person-group><year>2003</year><article-title>Helicobacter pylori-associated gastric cancer in INS-GAS mice is gender specific.</article-title><source>Cancer Res</source><volume>63</volume><fpage>942</fpage><lpage>950</lpage><pub-id pub-id-type="pmid">12615707</pub-id></citation></ref><ref id="pone.0004754-Wang1"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>TC</given-names></name><name><surname>Koh</surname><given-names>TJ</given-names></name><name><surname>Varro</surname><given-names>A</given-names></name><name><surname>Cahill</surname><given-names>RJ</given-names></name><name><surname>Dangler</surname><given-names>CA</given-names></name><etal/></person-group><year>1996</year><article-title>Processing and proliferative effects of human progastrin in transgenic mice.</article-title><source>J Clin Invest</source><volume>98</volume><fpage>1918</fpage><lpage>1929</lpage><pub-id pub-id-type="pmid">8878444</pub-id></citation></ref><ref id="pone.0004754-Wang2"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>TC</given-names></name><name><surname>Dangler</surname><given-names>CA</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Goldenring</surname><given-names>JR</given-names></name><name><surname>Koh</surname></name><etal/></person-group><year>2000</year><article-title>Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer.</article-title><source>Gastroenterol</source><volume>118</volume><fpage>36</fpage><lpage>47</lpage></citation></ref><ref id="pone.0004754-Elfvin1"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Elfvin</surname><given-names>A</given-names></name><name><surname>Bolin</surname><given-names>I</given-names></name><name><surname>Von</surname><given-names>BC</given-names></name><name><surname>Stolte</surname><given-names>M</given-names></name><name><surname>Watanabe</surname><given-names>H</given-names></name><name><surname>Fandriks</surname><given-names>L</given-names></name><name><surname>Vieth</surname><given-names>M</given-names></name></person-group><year>2005</year><article-title>Helicobacter pylori induces gastritis and intestinal metaplasia but no gastric adenocarcinoma in Mongolian gerbils.</article-title><source>Scand J Gastroenterol</source><volume>40</volume><fpage>1313</fpage><lpage>1320</lpage><pub-id pub-id-type="pmid">16334441</pub-id></citation></ref><ref id="pone.0004754-Honda1"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Honda</surname><given-names>S</given-names></name><name><surname>Fujioka</surname><given-names>T</given-names></name><name><surname>Tokieda</surname><given-names>M</given-names></name><name><surname>Satoh</surname><given-names>R</given-names></name><name><surname>Nishizono</surname><given-names>A</given-names></name><name><surname>Nasu</surname><given-names>M</given-names></name></person-group><year>1998</year><article-title>Development of <italic>Helicobacter pylori</italic>-induced gastric carcinoma in Mongolian gerbils.</article-title><source>Cancer Res</source><volume>58</volume><fpage>4255</fpage><lpage>4259</lpage><pub-id pub-id-type="pmid">9766647</pub-id></citation></ref><ref id="pone.0004754-Ogura1"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ogura</surname><given-names>K</given-names></name><name><surname>Maeda</surname><given-names>S</given-names></name><name><surname>Nakao</surname><given-names>M</given-names></name><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Tada</surname><given-names>M</given-names></name><etal/></person-group><year>2000</year><article-title>Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbil.</article-title><source>J Exp Med</source><volume>192</volume><fpage>1601</fpage><lpage>1610</lpage><pub-id pub-id-type="pmid">11104802</pub-id></citation></ref><ref id="pone.0004754-Mohammadi1"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mohammadi</surname><given-names>M</given-names></name><name><surname>Nedrud</surname><given-names>J</given-names></name><name><surname>Redline</surname><given-names>R</given-names></name><name><surname>Lycke</surname><given-names>N</given-names></name><name><surname>Czinn</surname><given-names>SJ</given-names></name></person-group><year>1997</year><article-title>Murine CD4 T-cell response to Helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load.</article-title><source>Gastroenterol</source><volume>113</volume><fpage>1848</fpage><lpage>1857</lpage></citation></ref><ref id="pone.0004754-Sawai1"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sawai</surname><given-names>N</given-names></name><name><surname>Kita</surname><given-names>M</given-names></name><name><surname>Kodama</surname><given-names>T</given-names></name><name><surname>Tanahashi</surname><given-names>T</given-names></name><name><surname>Yamaoka</surname><given-names>Y</given-names></name><etal/></person-group><year>1999</year><article-title>Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model.</article-title><source>Infect Immun</source><volume>67</volume><fpage>279</fpage><lpage>285</lpage><pub-id pub-id-type="pmid">9864227</pub-id></citation></ref><ref id="pone.0004754-Smythies1"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smythies</surname><given-names>LE</given-names></name><name><surname>Waites</surname><given-names>KB</given-names></name><name><surname>Lindsey</surname><given-names>JR</given-names></name><name><surname>Harris</surname><given-names>PR</given-names></name><name><surname>Ghiara</surname><given-names>P</given-names></name><name><surname>Smith</surname><given-names>PD</given-names></name></person-group><year>2000</year><article-title>Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice.</article-title><source>J Immunol</source><volume>165</volume><fpage>1022</fpage><lpage>1029</lpage><pub-id pub-id-type="pmid">10878379</pub-id></citation></ref><ref id="pone.0004754-Zavros1"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zavros</surname><given-names>Y</given-names></name><name><surname>Merchant</surname><given-names>JL</given-names></name></person-group><year>2005</year><article-title>Modulating the cytokine response to treat Helicobacter gastritis.</article-title><source>Biochem Pharmacol</source><volume>69</volume><fpage>365</fpage><lpage>371</lpage><pub-id pub-id-type="pmid">15652228</pub-id></citation></ref><ref id="pone.0004754-Beales1"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beales</surname><given-names>IL</given-names></name><name><surname>Calam</surname><given-names>J</given-names></name></person-group><year>1998</year><article-title>The histamine H3 receptor agonist N alpha-methylhistamine produced by Helicobacter pylori does not alter somatostatin release from cultured rabbit fundic D-cells.</article-title><source>Gut</source><volume>43</volume><fpage>176</fpage><lpage>181</lpage><pub-id pub-id-type="pmid">10189840</pub-id></citation></ref><ref id="pone.0004754-Prinz1"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Prinz</surname><given-names>C</given-names></name><name><surname>Neumayer</surname><given-names>N</given-names></name><name><surname>Mahr</surname><given-names>S</given-names></name><name><surname>Classen</surname><given-names>M</given-names></name><name><surname>Schepp</surname><given-names>W</given-names></name></person-group><year>1997</year><article-title>Functional impairment of rat enterochromaffin-like cells by interleukin 1 beta.</article-title><source>Gastroenterol</source><volume>112</volume><fpage>364</fpage><lpage>375</lpage></citation></ref><ref id="pone.0004754-Neu1"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Neu</surname><given-names>B</given-names></name><name><surname>Puschmann</surname><given-names>AJ</given-names></name><name><surname>Mayerhofer</surname><given-names>A</given-names></name><name><surname>Hutzler</surname><given-names>P</given-names></name><name><surname>Grossmann</surname><given-names>J</given-names></name><etal/></person-group><year>2003</year><article-title>TNF-alpha induces apoptosis of parietal cells.</article-title><source>Biochem Pharmacol</source><volume>65</volume><fpage>1755</fpage><lpage>1760</lpage><pub-id pub-id-type="pmid">12754112</pub-id></citation></ref><ref id="pone.0004754-Dockray1"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dockray</surname><given-names>GJ</given-names></name><name><surname>Varro</surname><given-names>A</given-names></name><name><surname>Dimaline</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name></person-group><year>2001</year><article-title>The gastrins: their production and biological activities.</article-title><source>Annu Rev Physiol</source><volume>63</volume><fpage>119</fpage><lpage>139</lpage><pub-id pub-id-type="pmid">11181951</pub-id></citation></ref><ref id="pone.0004754-Takaishi1"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takaishi</surname><given-names>S</given-names></name><name><surname>Cui</surname><given-names>G</given-names></name><name><surname>Frederick</surname><given-names>DM</given-names></name><name><surname>Carlson</surname><given-names>JE</given-names></name><name><surname>Houghton</surname><given-names>J</given-names></name><etal/></person-group><year>2005</year><article-title>Synergistic inhibitory effects of gastrin and histamine receptor antagonists on Helicobacter-induced gastric cancer.</article-title><source>Gastroenterol</source><volume>128</volume><fpage>1965</fpage><lpage>1983</lpage></citation></ref><ref id="pone.0004754-Bamford1"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bamford</surname><given-names>KB</given-names></name><name><surname>Fan</surname><given-names>X</given-names></name><name><surname>Crowe</surname><given-names>SE</given-names></name><name><surname>Leary</surname><given-names>JF</given-names></name><name><surname>Gourley</surname></name><etal/></person-group><year>1998</year><article-title>Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype.</article-title><source>Gastroenterol</source><volume>114</volume><fpage>482</fpage><lpage>492</lpage></citation></ref><ref id="pone.0004754-Zavros2"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zavros</surname><given-names>Y</given-names></name><name><surname>Rathinavelu</surname><given-names>S</given-names></name><name><surname>Kao</surname><given-names>JY</given-names></name><name><surname>Todisco</surname><given-names>A</given-names></name><name><surname>Del</surname><given-names>VJ</given-names></name><etal/></person-group><year>2003</year><article-title>Treatment of Helicobacter gastritis with IL-4 requires somatostatin.</article-title><source>Proc Natl Acad Sci U S A</source><volume>100</volume><fpage>12944</fpage><lpage>12949</lpage><pub-id pub-id-type="pmid">14555768</pub-id></citation></ref><ref id="pone.0004754-Fox4"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>JG</given-names></name><name><surname>Beck</surname><given-names>P</given-names></name><name><surname>Dangler</surname><given-names>CA</given-names></name><name><surname>Whary</surname><given-names>MT</given-names></name><name><surname>Wang</surname><given-names>TC</given-names></name><etal/></person-group><year>2000</year><article-title>Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy.</article-title><source>Nat Med</source><volume>6</volume><fpage>536</fpage><lpage>542</lpage><pub-id pub-id-type="pmid">10802709</pub-id></citation></ref></ref-list><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>This work was supported by grants from the Deutsche Forschungsgemeinschaft (RI 972/3-1) to GR and (SFB576) to RH and ERA-NET PathoGenoMics (0313930D) to RH. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.</p></fn></fn-group></back></article>